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"Where the hell is the pancreas, anyway? I don't even know what the damn thing does 
beside give you cancer." -Hawk Hawkins  
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I. INTRODUCTION 
Experimental animal models of human diseases are increasingly used from basic 
science to preclinical drug development (Barthold and others 2007, Sundberg and 
others 2012, Valli and others 2007). This implicates an urgent need for experts 
being in the position to examine these models for pathophysiological and 
pathohistological changes and therefore programs to train these experts (Cardiff 
2009). Despite the rising need for experts, training programs do not exist in Europe. 
Therefore, an international, web-based disease model training program for students 
with a higher university degree was developed within the frame of the Erasmus 
Lifelong Learning Programme (project No 517860-LLP-1-2011-1-FI-ERASMUS-
FEXI). Specialists in pedagogy, human and veterinary pathology, biochemistry and 
mouse models of human disease formed the consortium.  
As a test run for the training program, morphological phenotyping of a mouse model 
of pancreatic ductal adenocarcinoma (PDAC) was performed in this thesis using 
conventional histology, immunohistochemistry and morphometric analysis. For 
this purpose, a mouse line was generated by crossing the well-characterized mouse 
line for PDAC, the LSL-KRASG12D/+;Ptf1a+/Cre(ex1) mice (Siveke and others 2007) 
with mice deficient for the stromal protein Tenascin C (TNC) (Saga and others 
1992). Tumor-stroma interactions in PDAC, which is a very lethal disease, play a 
key role and contribute to the highly aggressive nature of this cancer type (Hwang 
and others 2008). TNC is overexpressed in the stroma surrounding the precursor 
lesions of PDAC and in the stroma of PDAC itself. The overexpression of the 
“large” splice variant of TNC characterizes the invasive and metastatic PDAC 
(Esposito and others 2006). Exogenous TNC promotes migration and invasion of 
pancreatic cancer cell lines and a mixed matrix of TNC and fibronectin blocks cell 
adhesion through activation of the integrin-signaling cascade (Paron and others 
2011).  
To investigate the functional role of TNC in PDAC progression in vivo, , LSL-
KRASG12D/+;Ptf1a+/Cre(ex1);TNC-/- (KC-TNCko) and LSL-KRASG12D/+; 
Ptf1a+/Cre(ex1);TNC+/-(KC-TNChet) mice where compared to LSL-KRASG12D/+; 
Ptf1a+/Cre(ex1) (KC) mice, focusing on a detailed morphological and 
histopathological analysis of this newly generated mouse strain. The aim of this 
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project was to acquire new knowledge of TNC function, in particular in the early 
phases of PDAC development.  
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II. LITERATURE REVIEW 
1. Web-based learning platform for comparative histology  
1.1. Comparative pathology and comparative medicine 
The term “comparative pathology” describes the pathology of laboratory animal 
diseases in comparison to human diseases. The American Heritage Medical 
Dictionary defines comparative pathology as “the pathology of animal diseases, 
especially in relation to human pathology” (Dictionaries 2008) meanwhile the 
Segen's Medical Dictionary offers the description “a field of science which 
compares specific human pathologies with those seen in natural animal models-e.g., 
diabetes insipidus in Brattleboro rats, which don’t produce vasopressin.” (Segen 
2005). Whilst in former times authors focused on comparing zoonosis in animals 
and humans, it was not before the 20th century that animal models for human 
diseases have been developed (Rader 2004). As animals have been increasingly 
used in research, in 1967 the National Institute of General Medical Sciences started 
a comparative medicine program to detect more animal diseases resembling human 
diseases. The members realized the importance of studying these animals to 
understand the underlying mechanisms of the particular disease and to gain insight 
in the disease process in humans. This knowledge would help to identify models 
for pharmacological, toxicological and drug development studies. The core 
disciplines of this comparative medicine program were pathology, physiology, 
psychology, anatomy and pharmacology. It was clearly stated that these basic 
disciplines and all medical professions should be involved to work hand in hand 
(Gay 1967, Nielsen 1983). Gay pointed out that comparative medicine is an 
interdisciplinary science and that it is important that medicine and veterinary 
medicine should exchange. They defined comparative medicine as “the study of 
phenomena basic to the diseases of all species” (Gay 1967). Nine years later, Bustad 
and others described the meaning of comparative medicine as “the study of the 
nature, cause and cure of abnormal structure and function in people, animals and 
plants for the eventual application, and benefit of all living things” (Bustad and 
others 1976).  
In the United States, education in laboratory animal medicine can be performed as 
a residency program or a postdoctoral fellowship. The first training program offered 
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was at the Bowman Grey Medical School, initiated in 1960. Shortly after, other 
training programs followed at the Tulane University, the Stanford University, the 
University of Florida, the Johns Hopkins University, the University of Missouri, 
the Edgewood Arsenal, Maryland and the Brooks Air Force Base, Texas. The 
Jackson laboratories started to offer a summer school program already in the year 
1924 (Fox 1985). Still, education in comparison of laboratory and human medicine 
and pathology remains elusive (Sundberg and others 2012).   
1.2. Lack of experts in animal modeling and pathology 
Over the past century, the laboratory mouse has become the model animal in many 
laboratories to mimic human diseases (Valli and others 2007). The mouse harbors 
many advantages – from cheap, small and easy to handle and to breed to the broad 
similarity of the murine to the human genome. After the human genome was almost 
completely revealed, the mouse was the first non-human species whose genome 
was sequenced. Ninety-nine % of the human genes are conserved in the murine 
genome (Mouse Genome Sequencing and others 2002). Additionally to these 
genetic similarities, most physiologic and pathologic characteristics have been 
shown to harbor similarities in mouse and human, as for instance nervous, 
cardiovascular, endocrine, immune, musculoskeletal and other organ systems 
(Rosenthal and Brown 2007). Mice and rats comprise 95% of the animals used in 
biomedical research. The remaining 5% are covered by several animal species as 
human- and non-human primates, cows, sheep, swine, dogs, cats, birds, rabbits, 
guinea pigs, hamsters, fish, frogs, nematodes, fruit flies, even yeasts and pea plans 
(Simmons 2008).  
The histopathological evaluation of animal models is a factor that might cause 
wrong interpretations if not properly carried out by an expert. Additionally, this 
histopathological evaluation might be frustrating even in simple cases because of 
unexpected events as leaky promoters, neomorphic or hypomorphic allelic 
expression instead of allelic deletion, microbial infections,  and genetically 
differences between murine strains,  since all these factors may affect  the 
phenotype (Sellers and Ward 2012). Several mouse strains harbor distinct 
pathological background lesions, as for example the commonly used BALB/cByJ 
strain displays hepatic steatosis already in young male animals (Serpi and others 
2013). Especially these lesions due to a distinct murine background strain might 
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cause severe differences in the genetically engineered mice (GEM) and should 
therefore always be considered to influence the result (Sellers and Ward 2012). 
Working with an experienced pathologist, educated in murine and human 
histopathology, is often undervalued. Cardiff and others published in 2008 a 
statistic depicting an enormous increase in publications working with GEM, 
meanwhile the number of pathologists working with GEMs is only slightly 
increasing. In 2003, the ratio publication dealing with knock-out mice to 
pathologists involved was about 5000 to 1300; meanwhile in 2006 it was over 7000 
to not even 2000 pathologists. (Cardiff and others 2008). Several studies and 
publications reveal a clear need for experts trained in animal models of human 
diseases and their distinct histopathology as this field has been expanding in the last 
20 years (Barthold and others 2007, Bouley and others 2009, Cardiff and others 
2008, Sundberg and others 2012).  
An important fact is the knowledge to distinguish normal background lesions of 
various mouse strains from the lesion of interest. Many mouse strains show 
abnormalities in their physiology without any pathological impact. This gap of 
pathological knowledge might cause publications of wrong interpretations. For 
instance, Fu and coworkers misinterpreted abnormally enlarged preputial glands as 
a teratoma, not knowing about the existence of these glands. The authors wrote an 
erratum to indicate this fact (Fu and others 2002). Ince and coworkers called this 
self-evaluation of slides by non-pathologists without involving an expert in 
comparative pathology a “do-it-yourself (DIY) pathology” (Ince and others 2008). 
Robert Cardiff addresses this problem in his paper “How to phenotype a mouse?”: 
“Without access to comparative pathologists, how can disease models be analyzed 
with confidence?”. He foresees an aggravation of this problem as e.g. the NIH 
Knockout Mouse Project (KOMP) generated numerous new mouse models which 
need to be analyzed histopathologically (Cardiff 2009).  
Although in the last years a growing list of resources as books, articles in journals 
and web pages have been developed to facilitate the pathologic analysis of rodents 
compared to humans (Bolon and others 2012), this material cannot replace a 
training course. Inasmuch as there is no specific training program included in the 
traditionally pathology residency core courses, the only chance to develop skills in 
this field is to learn by experience, being lucky enough to find a mentor providing 
the expertise. As these mentors, especially in Europe, are very rare, this might be 
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tricky. A specialist in comparative pathology not only needs to be trained in basic 
mouse biology which includes husbandry, pathogens, strain-specific diseases and 
also in modern biomedical research but also human pathology (Sundberg and others 
2012). Modern pathology training programs should include training in differences 
between mouse strains and their individual background lesions, gender differences, 
lesion in aging mice and embryonic development (Sellers and Ward 2012). A 
standardized morphological phenotyping is therefore necessary and it is important 
to depict differences in murine background strains (Mossbrugger and others 2007). 
Unfortunately, these requirements are not even completely achieved yet in the 
training program of veterinarian pathologists. In US, the American College of 
Veterinary Pathologists (ACVP) offers training in animal models used in 
biomedical diseases with spontaneous background lesions, and has workshops, 
which cover the human disease (http://www.acvp.org/). In Europe, the European 
College of Veterinary Pathologists (ECVP) has only included laboratory animal 
pathology in their training program, but offers summers schools, symposiums and 
meetings about comparative pathology (http://www.ecvpath.org/). In Germany, the 
training program is less defined, but includes laboratory animals 
(http://www.bltk.de/fileadmin/bltk/user_upload/Dokumente/images/stories/weiter
bildung/wb-2003/anlageI/22-0-fta-pathologie.pdf, [date: 01.10.2014]). New 
technologies as slide scanners and webmicroscopy offer the possibility not only to 
preserve rare, important material, but also to reach more people over distances and 
these resources or mentors might be easier to reach (Hamilton and others 2012). 
1.3. Advantages of e-learning 
The term e-learning describes a form of electronically supported learning and 
teaching (Kerres 2013) and has gained significant value in biomedical education. 
Existing learning strategies can be improved by providing new methods to already 
existing traditional learning techniques (Boeker and Klar 2006, Dev 2006). 
Different e-learning strategies have been described: passive, facilitated learning, 
interactive learner-system, learner-teacher and virtual reality learner-system 
(Maxwell and Mucklow 2012). E-learning offers the opportunity to improve 
learning with new tools, even though the participants are not in the same room. This 
includes animations that can be controlled by the user, exercises with self-
assessment and feedback, videos and podcasts that can be streamed on demand. 
Important assets of e-learning for students are the supply of material, which can be 
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easily accessed, an improved interactivity and the freedom not to follow time 
schedules. Web-based learning can be performed any time and in any location with 
internet-accesses, well suited to the students’ needs (Maxwell and Mucklow 2012). 
Especially in the field of medical education, e-learning offers the opportunity to 
create case studies which can be attended by the students, as for instance the 
CASUS system in German veterinarian universities (Borchers and others 2010). 
The University of Leipzig, Germany, uses Moodle as an e-learning platform to 
teach their students, offer courses and show curricula. Advantages for the teachers 
include the wide accessibility of material, which is easy to update once it is 
established, and the possibility to pursue the students learning activity. Potentially 
no time restriction interferes with the offered material and teachers are able to 
update the material any time. The disadvantage of e-learning is the time and 
personnel needed to set up a course. Nevertheless, e-learning does not exclude the 
teacher, a personal interaction is possible when needed and necessary. E-learning 
does not center the teacher, therefore students are able to work according their 
individual preferences (Salter and others 2014). Even more, e-learning can be 
individualized, tailored to the students pace of learning, making it a crucial tool for 
student’s education (Masic 2008, Maxwell and Mucklow 2012).  
1.4. Moodle 
Martin Dougiamas developed the user-friendly open-source course management 
system Moodle in 1999 to improve classical learning platforms. It offers a broad 
spectrum of tools to work with, for instance wiki, a chatting tool, databases, blogs, 
calendars and newswire. Moodle is freely available and simple to handle. The 
program is used in approximately 214 countries for more than 4,784,691 courses 
with over 45 million students and 1.1 million teachers (Bussieres and others 2012, 
Seluakumaran and others 2011). This widely used tool is beneficial for the 
provision of courses in universities, curricula, application of courses and 
examinations, as well as in the area of medical education to implement case reports, 
patient cases and macroscopical and histological pictures (Seluakumaran and others 
2011).  
1.5. Webmicroscope 
Virtual microscopes are increasingly used in medical education, ranging from 
dental students to veterinary students in every field of education, as well as 
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postgraduate programs. By digitalization of histological or histopathological slides, 
teaching collections can be used for web-based learning (Szymas and Lundin 2011). 
The usage of virtual slides offers many advantages regarding accessibility, 
efficiency, pedagogic features and costs. The slide can be accessed from every PC 
with an internet connection and all students can review the same slide, they do not 
need to be in the same classroom. Therefore, teachers are able to provide the best 
slides to all students. A webmicroscope is efficient, as students do not need to adjust 
the focus, condenser and lightening as with a traditional microscope and can 
therefore faster access the next slide. Annotations and group discussions offer a 
broad spectrum for teaching. However, in terms of didactical aspects, it should be 
considered teaching traditional microscopy as well to train students with the 
handling of a traditional microscope. Disadvantages of digital microscopy include 
mainly technical aspects, e.g. less resolution of low magnifications on the PC screen 
or difficulties in scanning artifacts in tissue (Dee 2009).  
1.6. Aim of the project 
Aim of this project was to develop a training program for researchers working with 
animal models and offer an international training course. A combination of animal 
model pathology and human pathology in this course should help researchers with 
their future work. To further validate the course system, a deeper morphological 
phenotyping of a mouse model for PDAC was performed, as described in section 
2.  
2. Pancreatic cancer and tenascin-C 
2.1. Pancreatic cancer 
There are many different cancers of the pancreas described, although the term 
pancreatic cancer is synonymously used for pancreatic ductal adenocarcinoma 
(PDAC), which accounts for more than 90 % of malignant neoplasia of the human 
pancreas (Bosman 2010, Maitra and Hruban 2008). PDAC is a tumor of the 
exocrine compartment of the pancreas, originating from cells with a ductal 
phenotype and accompanied by a dense stromal reaction, called desmoplasia 
(Maitra and Hruban 2008). This aggressive solid tumor is highly challenging to 
treat because of its extensive local invasion, early systemic dissemination, most 
often in liver, lung and peritoneum (Samuel and Hudson 2012). The desmoplastic 
stromal is reaction linked with a low perfusion rate leading to a reduced 
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accessibility of intravenously administered therapeutics (Wilson and others 2014).  
2.1.1. Epidemiology 
PDAC is a lethal disease with a dismal overall prognosis. In the EU and US it has 
become the fourth leading cancer death in 2013 and the eight leading cause for 
cancer related death worldwide. In the past 30 years, PDAC has shown little 
improvement in survival and cancer mortality and cancer predictions underscore 
this trend: PDAC is the only major cancer site with no predicted improvement of 
mortality rates (Malvezzi and others 2013, Siegel and others 2013). In the United 
States 45,220 patients have been newly diagnosed in 2013, which is an increase of 
3 % to the year 2012 (Wang and others 2013). The five year survival rate is below 
5 %, which accounts for the very aggressive nature of this cancer (Siegel and others 
2013). Known risk factors that have been identified are sex, age, race, rare genetic 
conditions, smoking, obesity, alcohol abuse, chronic and hereditary pancreatitis, 
diabetes and infectious diseases (Alsamarrai and others 2014, Wormann and Algul 
2013, Yadav and Lowenfels 2013). PDAC is predominantly a disease of the elderly; 
it is very seldom diagnosed in patients younger than 40 years, the mean age of the 
patients diagnosed is 73 years (Koorstra and others 2008, Maitra and Hruban 2008).  
2.1.2. Prognosis and therapy 
In addition to the dismal outlook, patients generally have a poor response to radio- 
and chemotherapy. Most patients are diagnosed in an advanced stage, as the tumor 
remains silent until it invades in other structures. Abdominal pain is often the first 
symptom of the disease, but at this time, the tumor is mostly beyond cure (DiMagno 
1999). Surgery is the only treatment with a chance for healing, but only a minor 
part of patients (15-20 %) qualifies for surgical resection (Sultana and others 2012). 
The median survival ranges from 2.5 months to 24.1 months, depending on the 
stage, with a median overall survival of less than 12 months (Bilimoria and others 
2007, Siegel and others 2012). To date, the standard chemotherapy is gemcitabine, 
although the gemcitabine-free FOLFIRINOX regimen (5-FU/folfinic acid, 
irinotecan and oxaliplatin) showed a higher median survival than gemcitabine alone 
(Heinemann and others 2012). An early detection of the disease might improve the 
worse prognosis and serum levels of many enzymes and antigens have been tested, 
but no reliable marker candidate has been detected so far (Hidalgo 2010, Locker 
and others 2006). Targeting the tumor stroma might be a promising therapy concept 
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in PDAC as it is characterized by a poor vascularization and a dense desmoplastic 
stroma which may contribute to impaired drug delivery and therefore resistance to 
chemotherapy (Neesse and others 2011). 
2.1.3. Precursor lesions of PDAC 
Different distinct precursor lesions of PDAC are described in the literature, 
including pancreatic intraepithelial neoplasia (PanIN), intraductal papillary 
mucinous neoplasm (IPMN) and mucinous cystic neoplasm (MCN). Compared to 
IPMNs and MCNs, PanIN are the most frequent precursor lesions. In contrast to 
PanIN lesions, IPMNs and MCNs are already established neoplasms (Maitra and 
Hruban 2008). More recently, another type of precursor lesion was proposed: 
atypical flat lesions (AFL) (Aichler and others 2012).  
Pancreatic intraepithelial neoplasia (PanIN) 
PanIN lesions are clearly defined and classified lesions in the WHO classification 
as follows.  PanIN are non-invasive, microscopic proliferative epithelial lesions 
arising in smaller pancreatic ducts and ductules and are subdivided into PanIN-1A, 
PanIN-1B, PanIN-2 and PanIN-3, depending on the degree of cytological and 
architectural atypia, always with a diameter less than 1 cm. PanIN-1A are flat 
epithelial lesions with minimal atypia. Characteristically, the cells are tall and 
columnar, containing abundant mucin with basal orientation and small, round to 
oval nuclei. The similar PanIN-1B lesions harbor additionally a papillary, 
micropapillary or basally pseudostratified architecture. PanIN-2 lesions are flat or 
papillary and show nuclear abnormalities as loss of polarity, nuclear crowding, 
enlarged nuclei, pseudo-stratification and hyperchromatism. Mitoses are a rare 
finding. PanIN-3 are papillary or micropapillary, lesions with marked atypia. 
Seldom, this lesions can be flat. Budding of epithelial cells into the lumen of the 
lesions and luminal necrosis can be found in these lesions. In addition, loss of 
nuclear polarity, dystrophic goblet cells, abnormal mitoses, nuclear irregularities 
and prominent nucleoli are a common finding (Hruban and others 2001, Kern and 
others 2001). These morphological alterations are accompanied by an accumulation 
of genetic alterations, summarized in Figure 1. 
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Figure 1: Progression model of pancreatic intraepithelial neoplasia (PanIN) and pancreatic ductal 
adenocarcinoma (PDAC) formation: Accumulation of genetic alterations leads to PanIN and finally 
PDAC formation, modified by author (Hruban and others 2006).  
Accordingly, murine PanIN are similarly defined as human PanIN (Hruban and 
others 2006).  
Intraductal papillary mucinous neoplasm (IPMN) 
In contrast to PanIN, IPMNs are lesions at least 1 cm in size, arising in the main 
pancreatic duct or branch ducts. Mucin production and papillary architecture are 
the histologic features of IPMNs (Furukawa and others 2005). IPMNs are 
subdivided into main-duct (21-36 %), branch-duct (40-48 %) and mixed duct types 
(16-38 %); branch-duct IPMNs usually have a foveolar appearance and are 
therefore called “gastric-type”, meanwhile main-duct IPMNs are histologically 
divided into the “intestinal-”, “pancreatobiliary-” and “oncocytic-type”, depending 
on morphological and immunohistochemical features. Progression to invasive 
PDAC is quite common in main-duct IPMNs (48-64 %) and less frequent in branch-
duct IPMNs (10-20 %) (Schlitter and Esposito 2012). The 5-year survival rate is 
depending on the histological subtype and ranges from 52 % 
(pancreatobiliary-type) to 84 % (oncocytic-type). PDAC arising in the context of 
IPMN have a better prognosis (Furukawa and others 2011).  
Mucinous cystic neoplasm (MCN) 
MCNs are mucin producing, cyst-forming epithelial neoplasms without 
communication with the pancreatic ducts and surrounded by a distinctive ovarian-
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type stroma, immunohistochemically expressing hormone-receptor antigens. These 
lesions are predominantly detected in women (98%). Histologically, MCNs can 
display low to high-grade dysplasia. One third of MCNs are resected with an 
associated invasive carcinoma. The 5-year survival for resected patients with 
noninvasive MCNs is almost 100 % and about 50 % for patients with invasive 
cancer (Crippa and others 2008, Hruban and Fukushima 2008).  
Atypical flat lesions (AFL) 
AFL have only recently been described as another type of potential precursor 
lesions. Discovered in the KC mice, the presence of this lesion was confirmed in 
non-tumorous specimen of individuals belonging to familial pancreatic cancer 
(FPC) kindred. AFL are proliferating, non-mucinous, flat ductal lesions with 
enlarged and hyperchromatic nuclei and prominent nucleoli surrounded by a fibrous 
and cell-rich stroma that can have a loose, myxoid appearance. Mitoses are a 
common finding. These lesions seem to arise from tubular complexes (TC) (Aichler 
and others 2012, Bockman 1997) in areas of tissue remodeling, so called acinar-
ductal metaplasia (ADM), and their frequency increases with the age of mice. 
Compared to PanIN, murine AFL display a higher proliferation activity (10-80 %), 
p53 positivity and stromal accumulation of αSMA (Aichler and others 2012). The 
consideration of AFL as precursor lesions might influence the controversial 
discussion whether PDAC arises from ductal, acinar or centroacinar cells (Guerra 
and others 2007, McDonald and others 2012). Figure 2 depicts a possible way of 
PDAC development from acinar and centroacinar cells.  
 
Figure 2: Possible carcinogenesis from AFL lesions, A: mouse, B: human. Atypical flat lesions 
(AFL) arise in a setting of acinar-ductal metaplasia (ADM) lesions with tubular complexes (TCs) 
A B
III. Literature Review     13 
and mucinous tubular complexes (MTCs), proposing the flat carcinogenesis model, modified by 
author (Aichler and others 2012). 
2.1.4. Genetic alterations 
PDAC develops as a result of successive accumulation of genetic alterations in pre-
neoplastic lesions, including mutations in the key driver genes KRAS, 
P16/CDKN2A, TP53 and SMAD4/DPC4.5 (Hruban and others 2000). The mutation 
of the oncogene KRAS is an early event in the development of PDAC, which can 
be detected in 92 % of PanIN-1A lesions. More than 95 % of human PDAC contain 
an activating point mutation in the KRAS gene, mainly changing codon 12 from 
glycine to aspartate or valine in exon 2. Further, mutations in codon 13 and 61 are 
observed occasionally (Almoguera and others 1988, Biankin and others 2012, 
Kanda and others 2012). Inactivation of the tumor suppressor gene CDKN2A gene 
is another early event in PDAC. Around 30 % of PanIN-1A lesions harbor a 
CDKN2A mutation, and more than 95 % of PDAC have an inactivated CDKN2A 
gene due to homozygous deletion, inactivation mutation in one allele and loss of 
heterozygosity or promoter hypermethylation (Ottenhof and others 2011). The 
subsequent loss of functional p16 protein leads to an increased cell cycle 
progression (Schutte and others 1997). A late event in the tumorigenesis of PDAC 
is the inactivation of the TP53 gene by missense mutation of one allele and 
subsequent loss of the second allele. It is mutated in about 75 % of PDAC and 
functional loss of the protein p53 leads to accumulation of further genetic 
abnormalities through anti-apoptotic effects in the presence of DNA-damage 
(Bardeesy and others 2006, Rozenblum and others 1997). Similar to TP53, 
inactivation of SMAD4 is found only in high-grade PanIN, indicating another late 
event in the progression to PDAC. Fifty-five % of PDAC cases harbor a SMAD4 
inactivation (Hruban and others 2000, Tascilar and others 2001).  
2.1.5. Stromal component and tumor microenvironment 
PDAC harbor a characteristic stromal reaction, called desmoplasia. This 
desmoplastic stroma is mainly found in PDAC, rarely in other pancreatic primary 
or secondary tumors of the pancreas and represents for up to 90 % of the tumor 
volume (Kloppel and others 2004). It is characterized by a deposition of 
extracellular matrix proteins and a cellular component consisting of stellate cells, 
activated fibroblasts and myofibroblasts, as well as inflammatory cells. The 
extracellular matrix proteins are synthesized mainly by pancreatic stellate cells 
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(PSC) and in a lower amount by cancer cells (Neesse and others 2011). The stroma 
acts as a mechanical barrier to the tumor, restricting the vascularity of the tumor 
and hereby limiting the effect of anti-cancer drugs. Hereby, it plays an important 
role in the process of tumor formation, progression, invasion and metastasis, 
protection from apoptosis and cancer stem cell maintenance (Hwang and others 
2008, Korc 2007).  
Another important key player of the tumor microenvironment is the immune 
system. Antigens associated to cancer are expressed by PDAC and competent CD4+ 
and CD8+ T cells with specific receptors against cancer antigens are expressed in 
the bone marrow of patients harboring PDAC (Schmitz-Winnenthal and others 
2006). Pancreatic cancer cells are known to be able to evade the immune system 
and cancer associated inflammation evident in the tumor stroma might serve as a 
barrier to the surveillance of the immune system (Bayne and others 2012).   
2.1.6. Mouse models of pancreatic cancer 
Animal models closely mimicking the human disease are helping to understand the 
pathogenesis of PDAC and to reveal the mechanism leading to invasive cancer. In 
2003, Hingorani and others generated a mouse model with a Cre recombinase 
dependent, endogenous, conditional Kras mutant allele on pancreas specific PDX-
1 or p48 promoters (see Figure 3). These mouse models develop low-grade and, to 
a less extent, high-grade PanIN, as well as ADM, closely resembling the human 
disease.  
 
Figure 3: Pancreatic development. Transcription factors that program the early progenitor cells in 
the developing murine pancreas are indicated. PDX-1 expression starts with embryonic day 8.5 and 
p48 expression begins with embryonic day 9.5. These progenitor cells develop to all cell linages of 
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the pancreas, modified by author (Hingorani and others 2003).  
As in human PDAC, a single Kras mutation leads not necessarily to invasive cancer 
(Hingorani and others 2003). Therefore, further genetic alterations have to be 
targeted e.g. Cdkn2a, Tp53, and Smad4 on a mutant Kras background, leading to 
fully invasive PDAC with metastases (Aguirre and others 2003, Hingorani and 
others 2005, Kojima and others 2007). A further breakthrough was the development 
of a doxycycline dependent, conditionally inducible Kras allele in the mouse, 
showing that the Kras mutation is required for the maintenance of ADM, PanIN 
and PDAC and that the inactivation of Kras leads to regression of PDAC (Collins 
and others 2012a, Collins and others 2012b).  
Models other than GEMs used to mimic human disease are heterotopic xenograft 
models, with subcutaneous implantation of human cancer cells in nude or severe 
combined immunodeficient (SCID) animals. Another possibility is the orthotopic 
xenograft model, with tissue grafted in the pancreas. The limiting factor of these 
two models is that the recipients are immunocompromised animals to avoid 
rejection of human tissues, so modulation of the tumor growth by the immune 
systems is lacking. Furthermore, these mice show only a minimal or no stromal 
reaction (Capella and others 1999, Ding and others 2010).  
In summary, transgenic mouse models of precursor lesions and PDAC offer new 
possibilities to test the validity of early detection methods and of therapeutic 
strategies and to investigate cellular origins and molecular pathways involved in the 
development, progression and invasion of PDAC.   
2.2. Tenascin-C 
Tenascin-C belongs to a family of large oligomeric extracellular matrix proteins, 
the tenascins (TN), displaying a distinct expression pattern during development, 
tissue maintenance and disease. TNC was detected by different working groups 
independently and former names include glioma mesenchymal ECM antigen 
(GMEM) (Bourdon and others 1983), hexabrachion (Erickson and Inglesias 1984), 
myotendinous antigen (Chiquet and Fambrough 1984), J1 glycoprotein (Kruse and 
others 1985) and cytotactin (Grumet and others 1985) until in 1986 Chiquet-
Ehrismann and others introduced the name tenascin (Chiquet-Ehrismann and others 
1986). TNC was the first tenascin described more in detail before other TNs even 
have been detected in humans including tenascin-R (TNR, restrictin, janusin), 
tenascin-X (TNX, gene X) and tenascin-W (TNW, tenascin-N), and additionally 
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tenascin-Y (TNY) in chicken (Jones and Jones 2000a). Tenascin was chosen as 
common name as it is a protein enrolled in the adhesion of cells (lat. “tenere”, to 
hold) (Mackie 1997) and the C in TNC stands for “cytoactin” (Chiquet-Ehrismann 
and Tucker 2011).  
The human TNC gene is localized on chromosome 9 in band q32-q34 (Rocchi and 
others 1991). TNC, as all TNs, consists of a common set of structural motifs, 
including heptad repeats, EGF-like repeats, fibronectin type III (FNIII) domains 
and a C-terminal globular domain. The disulfide linked oligomer consists of an 180- 
and an 300-kD subunit, linked together in a central core composing a hexabrachion 
(Figure 4) (Vaughan and others 1987).  
 
Figure 4: Structure of TNC: Schematic presentation of the hexameric TNC (A), and the TNC 
oligomer (B). The six oligomers are linked together at the tenascin assembly (TA) domain by coiled-
coil interactions in the HEPTAD region. The left arrow represents terminal cysteine residues. 
Mammalian TNC contains 14 EGFL repeats and 8-17 FNIII domains (black: conserved, white: 
alternatively spliced variants). The fibrinogen globe represents the C-terminal end, modified by 
author (Jones and Jones 2000b).  
Every arm contains an aminoterminal tenascin assembly (TA) domain in which the 
TNC polypeptides can be linked together by terminal cysteine residues and 3-4 α-
helical heptad repeats (Conway and Parry 1991). The TA domain is followed by 
14.5 epidermal growth factor-like (EGFL) repeats, each containing six cysteine 
residues, which participate in intrachain disulfide bonds. These EGFL repeats are 
important for the adhesion to fibroblasts and neurons (Fischer and others 1997). In 
A
B
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the carboxy-terminal direction, 8-17 fibronectin-III (FN-III) repeats are present, 8 
conserved and up to 9 alternatively spliced FN-III repeats (Pas and others 2006). 
The domains are arranged in two sheets of seven anti-parallel β-strands (Baron and 
others 1992) and account for the flexibility of TNC (Carr and others 1997). The 
FN-III repeats are altered by alternative splicing of TNC mRNA and distinct 
expression pattern of these slice variants have been described in development and 
disease, modulating the biological function of TNC (Esposito and others 2006, 
Jones and Jones 2000a). Interestingly, TNC promotes adhesive and anti-adhesive 
actions, depending on the binding to different EMC proteins or cell surface 
receptors. Alternative splicing does influence this binding, as it has been shown for 
the cell surface receptor annexin II, which binds to the alternatively spliced FN-III 
region A-D of the large TNC splice variant (Chung and Erickson 1994).  
The C-terminal end of TNC is represented by the fibrinogen (FG) globe, which 
contains polypeptide loops, formed by two disulfide bonds and has an Ca2+-binding 
site (Jones and others 1989). This domain interacts with other proteins of the ECM 
and cell surface receptors, e.g. collagens, integrins and heparins (Milev and others 
1997). These interactions promote TNC dependent activities, like migration, 
proliferation and regulation of cell adhesions (Orend 2005). Proteins like TNC, that 
contain binding sites for major structural proteins in the ECM and specific cell 
surface receptors are called “matricellular” proteins (Roberts 2011). Various effects 
of TNC on cell behavior are mediated through the existence of specific receptors. 
Different cell types are able to produce TNC, for instance stromal cells (Oskarsson 
and Massague 2012). In human brain, e.g. oligodendrocytes and astrocytes express 
different splice variants of TNC, oligodendrocytes the larger ones, meanwhile 
astrocytes the smaller ones (Garwood and others 2004).  
2.2.1. Tenascin-C in development and the adult organism 
TNC is expressed in a restricted pattern during embryogenesis and early postnatal 
development. It was detected at sides of tissue remodeling, in the mesenchyme 
around the epithelium undergoing differentiation, for instance in the mammary 
gland, the tooth bud formation, the early tubulogenesis in the kidney and the 
urogenital sinus at the sites of formation of prostatic buds and vagina. Organs that 
express highest levels of TNC are thymus, lung and cerebellum (Saga and others 
1991).  
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In the adult organism, TNC is tightly regulated and restricted to tissues which 
undergo either mechanical stress, such as tendons, ligaments and smooth muscles 
or exhibit a high cell turnover as lymphoid organs and hair buds in the skin 
(Chiquet-Ehrismann and others 2014). Examples for areas of restricted TNC 
expression in the adult organism are the basement membrane of the skin, mucosa 
of the colon, ductal salivary glands, vessel walls of various organs, visceral smooth 
muscle, the mammary gland after lactation and the uterus during estrus cycle and 
pregnancy (Juuti and others 2004, Saga and others 1992). Reappearance of TNC in 
adult tissue is triggered by injury and tissue regeneration as well as in healing 
wounds, arteriosclerosis and cancer (Chiquet-Ehrismann and Tucker 2011). As in 
vivo, TNC expression of most cultured cells is dependent on certain growth factors 
and hormones. For instance, TNC expression in cultured fibroblasts is only 
detectable after incubation with factors associated with inflammation and wound 
healing, like transforming growth factor-β, basic fibroblast growth factor and 
interleukin-1 (Chiquet-Ehrismann and others 1995).  
2.2.2. Tenascin-C and cancer 
Strong expression of TNC in the adult organism is found in the tumor 
microenvironment (Orend 2005). In most epithelial tumors, tumor-associated 
fibroblasts are the source of TNC, not the epithelial tumor cells themselves. 
Interestingly, in non-epithelial derived tumors, such as melanoma or glioblastoma, 
the tumor cells are the source of TNC. In epithelial tumors, immunohistochemistry 
reveals a fibrous network of TNC immunoreactivity surrounding tumor cell nests. 
A correlation between elevated expression of TNC and local infiltration of adjacent 
normal tissue and increased metastasis in many types of cancer was observed 
(Chiquet-Ehrismann and Tucker 2011). Moreover, TNC expression is upregulated 
during angiogenesis in inflammatory and neoplastic diseases. TNC concentrations 
have been linked to tumor recurrence and prognosis, but the findings are 
contradictory, underscoring the several functions of this protein (Orend and 
Chiquet-Ehrismann 2006). In breast cancer and colorectal cancer TNC expression 
is connected with worse prognosis, whereas in cervical and gastric cancer patients 
have a better prognosis with a TNC immunoreactivity in immunohistochemistry of 
tumor samples (Juuti and others 2004). TNC expression in breast cancer was 
investigated intensively. Here, it induces an epithelial-mesenchymal transition 
(EMT)-like change in breast cancer cells by binding of αvβ1 and αvβ6 integrins 
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(Katoh and others 2013). Another interesting feature is the fact, that often the large 
splice variant of TNC is associated with tumors. Borsi and others found that the 
extracellular matrix pH influences the splicing of TNC mRNA in normal 
fibroblasts, meanwhile malignant cells exclusively produce the large TNC mRNA 
(Borsi and others 1996). Antibodies against these splice variants might therefore 
play a role in diagnosis and therapy (Chiquet-Ehrismann and Chiquet 2003).  
2.2.3. Distribution and function of tenascin-C in pancreatic cancer 
Compared to normal tissue, the distribution of extracellular matrix proteins such as 
TNC differs in PDAC. TNC expression was found to be upregulated in PDAC, 
mostly in the stroma, surrounding tumor cells (Juuti and others 2004, Linder and 
others 2001). Juuti and others correlated immunohistochemical TNC detection with 
patient survival rate. They showed that TNC expression was associated with poorly 
differentiated tumor grades and patients age. No correlation between the expression 
of TNC and stage, tumor size, lymph node status, metastasis or tumor location could 
be detected. Interestingly, in male patients, TNC expression seemed to correlate 
with a higher survival (Juuti and others 2004). Gong and others detected a 
correlation between high levels of spliced TNC in sera of patients and gemcitabine 
resistance (Gong and others 2010). Esposito and others reported in 2006 that PSC 
are the main source of TNC, not the pancreatic cancer cells themselves. Here, they 
could show that the expression is induced by tumor necrosis factor alpha (TNFα) 
and transforming growth factor beta (TGF-β) (Esposito and others 2006). 
Large TNC splice variants have been found in precursors of PDAC and PDAC as 
well as in chronic pancreatitis, but not in normal pancreas and the expression 
intensity increases from low-grade PanIN to invasive PDAC. In normal pancreatic 
tissue, the distribution of TNC is restricted to the muscular wall of blood vessels 
and the stroma surrounding interlobular ducts (Esposito and others 2006). 
Functional analysis of TNC in vitro showed that TNC increases growth and 
adhesion of poorly differentiated pancreatic cancer cell lines. Moreover, using TNC 
as growing substrate the cell lines exhibited higher migration rate. Proliferation of 
pancreatic tumor cells was enhanced by TNC (Paron and others 2011). The role of 
TNC on apoptosis is not clear and results are sometimes controversial (Midwood 
and others 2011). However, these results indicate a possible tumor supportive role 
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of TNC in PDAC. Unfortunately, little is known about the role of TNC in the 
pancreas harboring only precursor lesions.  
2.2.4. Mouse models of tenascin-C 
In 1992, Saga and others succeeded in developing mutant mice lacking TNC. They 
replaced two-thirds of exon 2 and parts of intron 2 of the TNC gene with a lacZ 
gene, which induces lacZ expression instead of TNC. To their surprise, the mice 
developed normally and showed no obvious abnormalities (Saga and others 1992). 
Finally, in 1996, Forsberg and others independently generated a different mutant 
mouse model lacking the TNC gene and confirmed previous findings. TNC was 
deleted by switching the coding region of exon 2 to a neomycin gene (Forsberg and 
others 1996). However, TNC null mice showed some abnormalities as low body 
weight and low pregnancy rates. Fukamauchi and others first described abnormal 
behavior of TNC knockout mice. The mice exhibited a prolonged exploratory 
behavior in a new surrounding and had problems to habituate to the unknown 
circumstances (Fukamauchi and others 1996). Further, abnormalities in the central 
nervous system, development of lung and prostate as well as regenerative processes 
after injury and stress have been detected (Cifuentes-Diaz and others 2002, de 
Chevigny and others 2006, El-Karef and others 2007, Garcion and others 2004, 
Ishii and others 2008, Nakao and others 1998, Roth-Kleiner and others 2004). 
Moreover, it has been found that the TNC knockout mouse has a reduced 
inflammatory response (Chiquet-Ehrismann and Tucker 2011). Interestingly, 
knockout of other genes like Bcl-2, Smad8, Msx2 and MMP-19 seem to influence 
the expression of TNC and therefore the phenotype (Chiquet-Ehrismann and 
Tucker 2011), making it important to generate mouse models for special cancer 
types to elucidate the role of TNC in several cancer sites.  
2.3. Aim of the project 
Aim of this work was to compare an ablation of TNC in a mouse model of PDAC 
to a well-established mouse model of PDAC. Hereby, the focus was set to acquire 
new knowledge of TNC function, in particular in the early phases of PDAC 
development as this dismal disease has still a worse prognosis.  
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III. MATERIAL AND METHODS 
1. Web-based learning platform for comparative histology 
1.1. Material 
Material used during the course is listed in the annex. 
1.2. Methods 
1.2.1. Human tissue 
Tissue samples were obtained from the archive of the Institute of Pathology, 
Technische Universität München, Germany. After surgical removal, tissue samples 
were fixed in 4 % buffered formalin and embedded in paraffin after 24 hrs in a 
paraffin embedding machine. For routinely diagnostic purposes, histochemical and, 
if necessary, immunohistochemical stainings were performed, as described in detail 
in 2.2.2-2.2.6. The use of human material for this project was approved by the local 
ethics committee of the Technische Universität München, Germany, and written 
informed consent was obtained from all patients. 
1.2.2. Murine tissue 
Murine tissue slides of wild type mice were kindly provided by the mouse platform 
of the German Mouse Clinic (GMC), Helmholtz Zentrum München, Germany. The 
mice were housed and bred at the animal facilities of the GMC, in accordance with 
the German Animal Protection Law with permission from the responsible 
veterinary authority. Wild type mice were euthanized in a CO2 chamber, tissues 
were harvested, fixed in 4 % buffered formalin and embedded in paraffin after 24 
hrs. H&E staining of organ tissue sections were performed.  
1.2.3. Consortium 
The project was financed by ERASMUS Lifelong Learning, 517860-LLP-1-1-FI-
ERASMUS-FEXI. A network of universities teaching disease model pathology has 
been developed through the project. The consortium was composed by the Institute 
of Pathology, Technische Universität München, Munich, Germany, the Palmenia 
Centre for Continuing Education, University of Helsinki, Finland, Turku Center for 
Disease Modeling, University of Turku, Finland and the College of Medical, 
Veterinary and Life Sciences, University of Glasgow, Scotland. The members of 
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the consortium offered a broad knowledge and included specialists in pedagogy, 
medical and veterinary pathology and mouse models of human diseases.  
1.2.4. Development of a curriculum 
A curriculum for the web-based course content was developed. The structure for 
the overall curriculum was planned together by the members of the consortium 
using Moodle as an interactive web-based tool. Further discussions were hold by 
videoconferences and in face-to-face meetings. Quality criteria for a comprehensive 
learning, the e-learning content, the online tutoring and mentoring, the webinars, 
and the scanned slides utilized, have been applied in order to ensure that the 
curriculum was based on the latest research and pedagogical knowledge.  
1.2.4.1. Normal murine tissue 
Murine tissue slides from the mouse strains BALB/cByJ, C3HeB/FeJ, 
129P2OlaHsd, C57BL6/N, FVBNJ and C57BL6/J were obtained from the mouse 
platform of the Helmholtz Zentrum München. At least one representative female 
and male example with strain-specific background lesions was selected. H&E 
sections included murine brain (cerebrum, cerebellum, brainstem), neck 
(esophagus, trachea, thyroid, parathyroid), thoracic and abdominal organs (lung, 
heart, thymus, liver, kidney, spleen), reproductive organs (ovaries with fallopian 
tube, uterus, vagina, bladder, testes, epididymis, prostate), glands and lymph nodes 
(adrenal glands, salivary glands, lymph nodes) and gastrointestinal tract with skin 
(stomach, small intestine, large intestine, pancreas, skin).  
1.2.4.2. Basic lesions 
To highlight basic pathological lesions, appropriate human tissue sections were 
screened from the archive of the Institute of Pathology, Technische Universität 
München, Germany and interesting cases were selected. Tissue sections of animal 
models fitting to the human tissue sections were used from the mouse tissue archive 
of Prof. Dr. Esposito. Representative H&E slides as well as histochemical and 
immunohistochemical stains were used if important to understand the case. In 
detail, the chosen examples comprised cell adaptation reactions (hypertrophy, 
hyperplasia, atrophy and metaplasia), cell injury and death (apoptosis, necrosis), 
inflammation (acute, chronic, granulomatous) and tissue repair. Table 1 contains a 
detailed description of the murine and human lesions included in the course. 
III. Material and Methods     23 
 Cell reaction Human example Murine example 
Cell 
adaptations 
Hypertrophy Cardiac hypertrophy  
Leydig cell 
hypertrophy  
(AROM+ mouse 
model) 
 Hyperplasia Prostatic hyperplasia  
Adrenal subcapsular 
cell hyperplasia 
(incidental finding in a 
female BalbcbyJ 
mouse) 
 Atrophy Testis atrophy 
Testis atrophy 
(incidental finding in 
normal 129P2OlaHsd 
male mouse) 
 Metaplasia 
Gastric intestinal 
metaplasia  
Pancreatic acinar-
ductal metaplasia  
(cerulein induced 
acute pancreatitis, 
C57BL6N mouse 
strain) 
  
Squamous epithelial 
metaplasia cervix 
 
Cell injury and 
death 
Apoptosis 
Apoptotic bodies in 
viral hepatitis 
Wilson disease 
(Atp7b-/- rat model) 
(Zischka and others 
2011) 
  Lichen ruber 
Acute pancreatitis 
(cerulein induced 
acute pancreatitis, 
C57BL6N mouse 
strain) 
 Necrosis Acute liver failure 
Toxic liver necrosis 
(C57BL6N mouse 
strain, unexpected 
toxicity after 
experimental drug 
administration) 
  
Colliquative necrosis 
in acute pancreatitis 
Tumor necrosis liver 
(Wistar rat treated 
with 
Diethylnitrosamine to 
achieve hepatocellular 
carcinoma) 
  Cardiac infarction  
Inflammation 
Acute 
inflammation 
Acute 
bronchopneumonia 
Acute 
bronchopneumonia 
(incidental finding in a 
normal C57BL6N 
mouse) 
  Acute pancreatitis 
Acute pancreatitis 
(cerulein induced 
acute pancreatitis, 
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C57BL6N mouse 
strain) 
  Ascending cholangitis 
Ascending cholangitis 
(mouse model for 
sclerosing cholangitis, 
C57BL6N mouse 
strain) (Fickert and 
others 2002) 
 
Chronic 
inflammation 
Autoimmune 
pancreatitis 
Chronic pancreatitis 
(mouse model of 
immune modulated 
form of chronic 
pancreatitis, courtesy 
of Bo Kong, Surgical 
department, TUM) 
  
Primary sclerosing 
cholangitis 
Chronic cholangitis 
(mouse model for 
sclerosing cholangitis, 
C57BL6N mouse 
strain) (Fickert and 
others 2002) 
 
Granulomatous 
Inflammation 
Granulomatous 
hepatitis 
Granulomatous 
hepatitis 
(Helicobacter 
hepaticus infection in 
a female BalbcbyJ 
mouse) 
  
Foreign body reaction 
skin 
 
Tissue repair Fibrosis Liver cirrhosis 
Liver cirrhosis 
(chemically induced 
liver cirrhosis, Wistar 
rat with oral 
administration of 
dibromoacetic acid) 
  Keloid  
 
Table 1: Detailed content of the Webmicroscope module “Basic lesions” 
1.2.5. Digitalization  
Digital images of appropriate histochemical and immunohistochemical sections for 
the use in the Webmicroscope were obtained with a five-slide scanner (ScanScope 
CS, Aperio) at 40X magnification (0.25 µm/pixel resolution). Images were saved 
in the fastest to process .svs file format with a .jpg compression to minimize the file 
size. Images were stored on small hard drives and sent to the partners in Finland to 
upload them in the Webmicroscope. 
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1.2.6. Annotation of slides in the Webmicroscope 
Annotation of the slides was performed after uploading to the Webmicroscope 
server. Four different signs (circle, rectangle, polygon and arrow) and five colors 
(yellow, red, green, blue and black) were available in the Webmicroscope slide 
viewer. A new annotation was opened and the lesions were described by using the 
signs and colors. Normal murine histology of organs and relevant background 
lesions were highlighted in the common mouse strains BALB/cByJ, C3HeB/FeJ, 
129P2OlaHsd, C57BL6/N, FVBNJ and C57BL6/J. In the basic lesions part, 
important features of the changes seen in the particular organs were highlighted and 
short introductions towards cases, mouse strains and background information of the 
underlying diseases were prepared. Additional features were annotated as well.  
1.2.7. Pilot Course 
A part of the developed curriculum was carried out in the Pilot Course, which was 
run from 15.04.2013 to 30.06.2013. Additionally, two final examinations in July 
and in August were hold. Students were recruited in January 2013. After the Pilot 
Course, feedback was collected from the students. Each module of the Pilot Course 
was evaluated separately in terms of quality of the instruction, the course material 
and the organization of the course modules. Additionally, the students evaluated 
their own learning progress and improvement and the relevance of the course for 
their work. Moodle was used as an e-learning environment for the course platform 
and internal communications of teachers and students. The content of the Pilot 
Course focused on comparative pathology in mice and humans. This included 
PowerPoint presentations linked to a virtual microscope (Webmicroscope, hosted 
by the University of Turku, Finland, prepared by the Technische Universität 
München), video clips (prepared by the University of Turku and Helsinki), recorded 
lectures (prepared by every partner, voice over spoken by Prof. VD Janet Patterson-
Kane, University of Glasgow, Scotland) and interactive exercises (prepared by 
every partner in the corresponding module). Information about the Pilot Course was 
distributed via a public website designed for the project (http://pathpath.eu) by the 
University of Helsinki, Finland.  
2. Example for phenotyping of a mouse strain: The TNC 
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model 
2.1. Material 
Material used during the course is listed in the annex and relevant material as 
follows.  
2.1.1. Antibodies 
Primary antibodies 
 
Secondary antibodies 
 
Product  Application/Dilution Company 
Anti-claudin-18 IHC (1:1000) Life Technologies GmbH, Darmstadt  
Anti-cleaved caspase-
3 
IHC (1:1000) New England Biolabs, Frankfurt  
Anti-E-cadherin IHC (1:100) New England Biolabs, Frankfurt  
Anti-HES1 IHC (1:50) 
Biozol Diagnostica Vertrieb GmbH, 
Eching  
Anti-Ki-67 IHC (1:200) 
BD Transduction Laboratories, 
Heidelberg  
Anti-notch2 IHC (1:10) DSHB, Iowa (USA) 
Anti-p16 IHC (1:200) 
Santa Cruz Biotechnology, Inc., 
Heidelberg 
Anti-tenascin-C IHC (1:1000) Abcam plc., Cambridge (UK) 
Anti-TROMA III 
(CK19) 
IHC (1:800) DSHB, Iowa (USA) 
Anti-β-catenin IHC (1:500) 
BD Transduction Laboratories, 
Heidelberg  
Product   Application/Dilution Company 
Biotin-labeled goat anti-
mouse IgG 
IHC (Ready to use) KPL, Inc., Gaithersburg (USA) 
Biotin-labeled goat anti-
rabbit IgG 
IHC (Ready to use) KPL, Inc., Gaithersburg (USA) 
Dako EnVision+ System- 
HRP, Labelled Polymer 
Anti-Mouse 
IHC (Ready to use) 
Dako Deutschland GmbH, 
Hamburg  
Dako EnVision+ System- 
HRP, Labelled Polymer 
Anti-Rabbit 
IHC (Ready to use) 
Dako Deutschland GmbH, 
Hamburg  
Biotinylated anti-rat IgG 
(H+L) 
IHC (1:300) 
Vector Laboratories Inc., 
Burlingame (USA) 
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2.1.2. Primer pairs 
Primer sequences used for genotyping of mutant mice:  
Primer Tenascin-C genotyping 
TN-G-1-2 (FW) 5’-GAA GTC ACT AGA AAC TAG TGG ACA ACT C-3’ 
TN-150R 
(~3’TN) (RE) 
5’-AAG CTA GAA AGA TGC CTG GC-3’ 
TN-lacZ (RE) 5’-CTC CAT GCT TGG AAC AAC GAG CGC AGC-3’ 
 
Primer KrasG12D genotyping 
K004 (FW) 5’-GTC GAC AAG CTC ATG CGG GTG-3’ 
K005 (FW) 5’-AGC TAG CCA CCA TGG CTT GAG TAA GTC TGC A-3’ 
K006 (RE) 5’-CCT TTA CAA GCG CAC GCA GAC TGT AGA-3’  
 
Primer Cre/Ptf1α genotyping 
C001 (FW) 5’-ACC AGC CAG CTA TCA ACT CG-3’  
C002 (RE) 5’-TTA CAT TGG TCC AGC CAC C-3’ 
C003 (FW) 5’-CTA GGC CAC AGA ATT GAA AGA TCT-3’ 
C004 (RE) 5′-GTA GGT GGA AAT TCT AGC ATC ATC C-3′ 
2.2. Methods 
2.2.1. Animals 
All mice were housed and bred at the animal facilities of the German Mouse Clinic, 
Helmholtz Zentrum Munich. All work with the mice was carried out in accordance 
with the German Animal Protection Law with permission from the responsible 
veterinary authority. TNC-/- animals were breed with LSL-KrasG12D/+ and 
Ptf1a+/Cre(ex1) mutant mice on a C57BL6N background to obtain triple mutant mice 
(KC-TNChet and KC-TNCko). LSL-KrasG12D/+ and Ptf1a+/Cre(ex1) mice were breed 
to obtain double mutant mice (KC). Relevant mice and corresponding littermate 
controls were euthanized in a CO2 chamber. Mutant pancreata were harvested after 
15, 12, 9, 6, 3, 2 and 1 months. 
2.2.2. DNA extraction from mouse tails 
At weaning, three weeks old mice were anesthetized with isoflurane for 
identification with ear punching and tail clipping for DNA analysis. 0.2 - 0.5 cm of 
the tail were cut and bleeding was stopped with silver nitrate. For evaluation of 
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mutant mice, each mouse tail was incubated with 250 µl tail lysis buffer (50 mM 
TRIS-HCL pH 8.0, 100 mM EDTA, 100 mM NaCl, 1 % SDS, 0.5 mg/ml proteinase 
K) at 55 °C overnight on a gently rocking platform (700rpm). 200 µl of aqua ad 
iniectabilia and 200 µl phenol-chloroform-isoamyl alcohol were added to the tissue 
lysate, mixed by repeated inversion and centrifuged for 15 min at 13.000 rpm at 
RT. The upper aqueous layer was transferred to a new tube and 200 µl chloroform 
isoamyl alcohol (24:1) was added. The lysate was mixed and centrifuged as 
described above. The upper aqueous layer was transferred to a new tube. DNA 
precipitation was performed with 800 µl of cold ethanol 100 %. The precipitated 
DNA was centrifuged for 15 min at 13.000 rpm at 4 °C and the supernatant 
discarded. The same step was repeated with 400 µl of ethanol 70 %. After removing 
the supernatant, DNA was dried at 40 °C and resuspended in 30 µl aqua ad 
iniectabilia. DNA concentration and quality was measured by reading absorbance 
at 230, 260 and 280 nm and diluted to 100 ng/µl for further PCR analysis. 
2.2.3. PCR for mouse genotyping 
Genotyping Master Mix  1.16X   
10X buffer (15 mM Mg2+) 1.74 mM  
dATP    232.56 μM 
dCTP    232.56 μM 
dGTP    232.56 μM 
dTTP    232.56 μM 
Cresol Red sodium salt  46.51 μg/ml 
Sucrose              6.98 %  
 
For the TNC (wild-type presence) PCR a 25 µl reaction was set as follows: 
Genotyping Mastermix 21.5 μl  
Primer G1-2                        1.0 μl  
Primer 3’TN   1.0 μl  
Taq polymerase  0.5 μl  
DNA      1.0 μl  
For the LacZ (TNCko presence) PCR a 25 µl reaction was set as follows: 
Genotyping Mastermix 21.5 μl  
Primer G1-2                        1.0 μl  
Primer lacZ   1.0 μl  
Taq polymerase  0.5 μl  
DNA      1.0 μl  
The amplification parameters were set as following: 
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95 ° C   5 min initial denaturation 
35 cycles with: 
94 °C   1 min denaturation 
60 °C  2 min annealing  
72 °C   1 min elongation 
72 °C   10 min final elongation 
 
For the wtKras (Kras wild-type presence) PCR a 25 µl reaction was set as follows: 
Genotyping Mastermix 21.5 μl  
Primer K004 (FW)                 1.0 μl  
Primer K006 (RE)  1.0 μl  
Taq polymerase  0.5 μl  
DNA       1.0 μl  
For the mutKras (KrasG12D/Lox presence) PCR a 25 µl reaction was set as follows: 
Genotyping Mastermix 21.5 μl  
Primer K005 (FW)                 1.0 μl  
Primer K006 (RE)  1.0 μl  
Taq polymerase  0.5 μl  
DNA       1.0 μl  
The amplification parameters were set as following: 
95 ° C   5 min initial denaturation 
35 cycles with: 
95 °C   1 min denaturation 
60 °C  1 min annealing  
72 °C   1:30 min elongation 
72 °C   10 min final elongation 
 
For the Cre/Ptf1α (Cre presence and internal PCR control) PCR a 27 µl reaction 
was set as follows: 
Genotyping Mastermix 21.5 μl  
Primer C001 (FW)                 1.0 μl  
Primer C002 (RE)  1.0 μl  
Primer C003 (FW)                 1.0 μl  
Primer C004 (RE)  1.0 μl  
Taq polymerase  0.5 μl  
DNA       1.0 μl  
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The amplification parameters were set as following: 
95 ° C   5 min initial denaturation 
35 cycles with: 
95 °C   1 min denaturation 
60 °C  1 min annealing  
72 °C   1:30 min elongation 
72 °C   10 min final elongation 
Each PCR set included a positive and a negative control. The amplification product 
was visualized by gel electrophoresis on 1 % agarose gel in TBE containing 
0.5 μg/ml ethidium bromide. Gel images were taken with a gel documentation 
system. 
2.2.4. Murine tissue collection 
Tissue samples were obtained from mice after euthanasia. After resection, the 
harvested pancreas was cut parallel to the longitudinal axis of the organ. One half 
was fixed in 4 % neutral buffered formalin and embedded in paraffin after 24 hrs 
with a paraffin embedding machine (Medite GmbH, Burgdorf) for subsequent 
histological and immunohistochemical analysis. The other half was submerged in 
RNAlater® and stored at -80 °C for future molecular analyses. 
2.2.5. Hematoxylin and eosin stain (H&E) 
For H&E staining, 3 µm tissue sections were were cut on a microtome, mounted on 
microscope slides and dried overnight. After heating in the oven for 30 min at 65 °C, 
sections were dewaxed in xylene and rehydrated with ethanol and distilled water. 
Subsequently, the sections were stained for 5 min with hematoxylin for nuclear 
staining. The slides were washed with running tap water for 5 min to obtain 
differentiation. Eosinophilic structures were stained for 5 min with eosin. Finally, 
the slides were washed in running tap water and dehydrated in alcohol and xylene. 
To protect the tissue, coverslips were mounted with a drop of mounting medium. 
2.2.6. Masson-Goldner trichrome stain 
Paraffin fixed tissues were dewaxed and rehydrated as described above. Then the 
sections were stained for 10 min with Weigert’s iron hematoxylin for nuclear 
staining. Between each staining the sections were rinsed in distilled water and 
differentiated in 1 % acetic acid. The slides were stained with Ponceau S dye for 
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4 min, with phosphotungstic acid hydrate-Orange G for 4 min and with light green 
for 4 min. Dehydration and tissue protection was performed as described above. 
Muscle fibers were stained red, fibrin pink, collagens green, nuclei black and 
erythrocytes red.  
2.2.7. Alcian Blue-Periodic acid-Schiff reaction (PAS) stain 
Paraffin fixed tissues were dewaxed and rehydrated as described above. 
Subsequently, the sections were dipped in 3 % acidic acid for 2 min and stained for 
5 min with Alcian Blue stain. The slides were rinsed with tap water for 1-2 min and 
transferred to an automatic stainer. Here, the sections were immersed in sodium-
periodate for 5 min and 15 sec in 70 % ethanol before staining them with PAS with 
for 6 min. Before and after staining with Mayer’s hematoxylin, the slides were 
rinsed with running tap water. Dehydration and tissue protection was performed as 
described above. Acidic mucins were stained blue, neutral mucins magenta, mixed 
mucins blue to purple and nuclei blue.  
2.2.8. Movat’s pentachrome stain (Verhoeff) 
Paraffin fixed tissues were dewaxed and rehydrated as described above. 
Subsequently, the sections were pretreated in 3 % acetic acid for 30 sec and stained 
for 30 min with 1 % Alcian Blue stain. The slides were rinsed with tap water for 2 
min and stained for 8 min with Verhoeff solution for nuclear staining. Following 
this, the slides were differentiated in 1% aqueous ferric chloride for 1 min and 
rinsed in tap water for 10 min. Subsequently, the slides were stained for 6 min in 
crocein scarlet-acid fuchsine for cytoplasmic staining, followed by differentiation 
in 1 % acetic acid. Then the slides were placed in 2 % phosphotonungstic acid, 
differentiated in 1 % acetic acid for 1 min and treated in 99 % ethanol for 3 and 15 
min. Last step was a stain for 15 min in safron du gatinais for staining of fibers. 
Dehydration and tissue protection was performed as described above. Nuclei and 
elastic fibers are stained blue-black (in the murine pancreatic tissue nuclei are 
stained grey-red), collagen fibers and reticular fibers yellow, matrix and mucin 
blue, elastic fibers and muscle red.  
2.2.9. Immunohistochemistry 
For immunohistochemistry, 2-3 µm tissue sections were mounted on Superfrost® 
Plus microscope slides and dried overnight at 37 °C. After heating in the oven for 
30 min at 65 ° C, sections were dewaxed in xylene and rehydrated in a graded series 
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of ethanol (2x 100 %, 2x 96 %, 2x 70 %) and distilled water. Heat induced epitope 
retrieval (HIER) was performed in a pressure cooker with citrate buffer or in a water 
bath with EDTA buffer for each 20 min (see table 2), slides were then allowed to 
cool down in the buffer for 30 min. Staining was either performed manually or with 
the Dako Autostainer Universal Staining System (AS) in a humified chamber. 
Endogenous peroxidase activity was blocked in 3 % H2O2 for 10 min or with 
Universal Block for 20 min. Non-specific binding sites were blocked by either 
rabbit serum or goat serum diluted in TBS (manually) or washing buffer (AS) for 
30 min according to the host species of the secondary antibody. Primary antibodies 
with adequate dilution in antibody diluent were applied over night at 4 °C 
(manually) or for 2 hr at room temperature (RT) (AS), dilution see table 2. Positive 
and negative controls were used to determine a successful result. Subsequently, the 
slides were washed three times in TBS/washing buffer and the matching 
biotinylated secondary antibody was added for 30 min at RT. Slides were washed 
again three times with TBS/washing buffer before streptavidin-horseradish 
peroxidase was added, when needed, for 30 min at RT. If a polymer detection 
system was used, the last two steps were replaced by adding Dako Envision for 30 
min at RT. After another washing step colorimetric detection was performed using 
diaminobenzidine (DAB). The color reaction was observed under the microscope 
and stopped with distilled water. Counterstaining with hematoxylin for 10 min was 
performed followed by differentiation under running tap water. Dehydration and 
tissue protection was achieved as described above. 
Antibody Type Dilution HIER 
Serum 
blocking 
Secondary 
antibody 
Anti-β-catenin AS 1:100 
citrate 
buffer 
3 % goat 
serum 
Envision anti-
Mouse 
Anti-claudin-18 AS 1:1000 
citrate 
buffer 
3 % goat 
serum 
goat-anti-rabbit 
Anti-cleaved 
caspase-3 
man. 1:800 
citrate 
buffer 
3 % goat 
serum 
goat-anti-rabbit 
Anti-E-cadherin AS 1:200 
citrate 
buffer 
3 % goat 
serum 
goat-anti-rabbit 
Anti-HES1 man. 1:50 
citrate 
buffer 
10 % rabbit 
serum 
rat-anti-rabbit 
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Table 2: Primary antibodies used for murine tissue sections 
2.2.10. Markers for PDAC in humans and mice 
p16 
P16 can be seen as a connection between the control of cell cycle and cancer 
development (Serrano 1997). In physiological conditions, p16 controls the G1-S 
check-point of the cell cycle by inhibiting the kinase activity of the CDK4/6, thus 
preventing the phosphorylation of Rb. The expression of p16 is increased by 
different factors, including aging, exposure to DNA-damaging agents, and 
oncogenes and it is an important regulator of senescence (Rayess and others 2012). 
In PDAC and in its precursor lesions genetic and epigenetic events inactivate the 
p16 tumor suppressor, thereby overcoming the induction of cell senescence 
(Ottenhof and others 2011). 
Ki67 
Ki67 is a nuclear antigen. The protein is absent in quiescent cells in G0, but 
universally expressed in cells that proliferate. Therefore, Ki67 serves as a 
proliferation marker (Pathmanathan and Balleine 2013). The evaluation of 
proliferation in mice has to be performed carefully, taking into account that the rate 
of cell division in pancreatic mice parenchyma reaches its maximum between 15 
and 30 days after birth. In this period of rapid growth, centroacinar, ductal and 
acinar cells exhibit similar mitotic indices (Dore and others 1981). 
Cleaved caspase-3 
Cleaved caspase-3 can be used as a marker of apoptosis. Sequential activation of 
caspases is a central step in both pathways of the apoptotic process. Caspase-3 is an 
apoptosis related cystein-aspartic acid protease and an effector caspase. After 
Anti-Ki-67 AS 1:200 
citrate 
buffer 
3 % goat 
serum 
goat-anti-rabbit 
Anti-notch2 man. 1:50 
citrate 
buffer 
10 % rabbit 
serum 
rat-anti-rabbit 
Anti-p16 man. 1:200 
citrate 
buffer 
10 % goat 
serum 
goat-anti-rabbit 
Anti-TROMA III 
(CK19) 
AS 1:800 
EDTA 
buffer 
3 % rabbit 
serum 
rat-anti-rabbit 
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cleavage through initiator caspases, caspase-3 activates downstream targets. 
Antibodies against cleaved caspase-3 detect cells that undergo apoptosis 
(Kuribayashi and others 2006). 
CK19 
Cytokeratin 19 belongs to the keratin family, and is an important marker for 
immunohistochemical evaluation of tumors. Under normal conditions, CK19 is 
expressed in normal ductal epithelium. PanIN lesions, MTCs and PDAC express 
CK19 (Jain and others 2010). PanIN lesions are defined as ductular lesion with a 
size less than 1 mm, arising of pancreatic ducts in a setting of unaffected acinar 
parenchyma (Hruban and others 2006).  
Claudin-18 and other adhesion molecules 
Claudin-18 (CLN-18), a tight-junction protein, is under physiological conditions 
only expressed in human body in the gastric epithelial cells and lung. The splice 
version 2, CLN-18.2 was described as a novel, specific marker for precursor lesions 
of PanIN and PDAC. Normal human acinar parenchyma, ductal cells and islet cells 
show no membranous immunoreactivity for CLN-18 (Tanaka and others 2011, 
Woll and others 2014). The Wnt signaling pathway components E-Cadherin and β-
catenin are important for epithelial-to-mesenchymal transition (EMT). EMT acts as 
an important factor in fibrosis of tissue and in development of cancer (Tian and 
others 2011). 
Notch signaling  
In cancerous tissue, the embryonic signaling pathway Notch is reactivated and leads 
to progression of the tumor growth and promotes insensitivity towards 
chemotherapy. Wörmann and Algül showed that in PDAC Notch ligands and 
receptors are upregulated when compared to normal pancreatic tissue. The Notch 
components seem to promote development of PanINs and PDAC (Wörmann and 
Algül, 2013). Although the Notch signaling pathway is apparently necessary in the 
early development of the pancreas, it is suppressed in the adult organ (Jensen and 
others 2000). The transcription factor Hes1 is a downstream target gene of the Notch 
pathway. It is nuclear expressed by an activation of Notch pathway. Hingorani and 
others described the PanIN lesions of their mutant mice to be strongly positive for 
nuclear und weakly positive for cytoplasmic Hes1 expression, but not in the normal 
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pancreas except in centroacinar cells (Hingorani and others 2003, Miyamoto and 
others 2003). 
2.2.11. Analysis of histo- and immunohistochemical stainings and reactions 
Stainings and immunoreactions were analyzed either semi-quantitatively or 
quantitatively, as described below.  
Masson-Goldner-Trichrome 
Analysis of Masson stain was performed in collaboration with Raisa Serpi, PhD, 
Biocenter Oulu, Finland. In detail, slides were scanned at 20X magnification, 
computer aided analysis was performed by discrimination of stained pixels and 
percentage of architectural distorted areas (stained green) to whole tissue area 
(stained red and green) was calculated.  
Alcian Blue-PAS 
Analysis of Alcian Blue-PAS stain was done in collaboration with Jussi Kupari, 
MSc, Institute of Biomedicine, University of Helsinki, Finland. In detail, digital 
images were captured from five random areas filled with ductular lesions at 10X 
magnification from three different slides per animal to achieve a total number of 15 
images/animal. ImageJ with the “color deconvolution”-plugin 
(http://www.mecourse.com/landinig/software/cdeconv/cdeconv.html) was used to 
analyze the slides, as this plugin can discriminate between different histochemical 
stains. Vectors for Alcian Blue (AB) and hematoxylin (H) and PAS and H were 
used to analyze the AB and PAS staining on the sections (Ruifrok and Johnston 
2001). The images were transformed to grayscale (8-bit) and opened with the “color 
deconvolution”-plugin. The analysis was first performed on AB and H and then 
repeated for PAS and H. The information received for hematoxylin was not used. 
The threshold was set on the level where minimum nonspecific signal was seen. 
The area covered by AB and PAS was then measured and the full tissue area of the 
image was calculated. The ratio of mucin covered (PAS, AB) area/total tissue area 
was calculated for all images.  
Movat pentachrome stain 
Movat pentachrome stain was analyzed in collaboration with Dr. rer. nat. Annette 
Feuchtinger, Helmholtz Zentrum München, Germany. Slides were scanned at 20X 
magnification and Definiens software (Tissue Studio, Definiens) was used to 
III. Material and Methods     36 
discriminate colors of different stained areas. Normal ductular structures and 
vessels were excluded from the analysis. Architectural distorted areas with fibrosis 
were calculated and set in percentage to the completely analyzed area. Figure 5 
shows an example of the color deconvolution.  
 
Figure 5: Mutant pancreata of a KC animal, stained with Movat stain, 10x, B: Color deconvolution 
to calculate fibrotic areas, 2x 
Anti-TROMA III (CK19), Anti-claudin-18, anti-E-cadherin, anti-β-catenin 
These proteins showed a membranous staining pattern and had therefore been 
selected for computer based analysis. Slides were scanned at a 20X magnification 
with the Aperio CS System and evaluated with Aperio’s Area Quantification Color 
Deconvolution Software (Spectrum, Aperio). Percentage of stained area to whole 
area was measured. Anti-TROMA III (CK19) analysis was performed in 
collaboration with Raisa Serpi.  
Anti-Ki-67, anti-cleaved caspase-3, anti-p16, anti-notch2, anti-HES1 
The expression of these markers was evaluated focusing on regions of interest. In 
detail, five random areas of architectural distortion or precursor lesions were 
selected and at least 100 cells were counted. The percentage of positive cells was 
then assessed.  
2.2.12. Data evaluation and statistical analysis 
Results are expressed as arithmetic mean ± standard error of the mean. Statistical 
analysis was performed in cooperation with Dr. Alexander Hapfelmeier, Institut für 
Medizinische Statistik und Epidemiologie, TUM, using the software IBM SPSS 
Statistics 21 for Windows and Microsoft Excel software. Normality was tested and 
two-way analysis of variance student’s t-test was used to determine the significance 
and p-values < 0.05 were considered significant. Graphs were generated using 
Microsoft Excel software. 
A B
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IV. RESULTS 
Aim of this project was to develop a web-based online course for disease model 
pathology, which is reported in section 1. With the knowledge gained during 
development and hosting of the course, a subsequent characterization of a tumor 
model for pancreatic cancer was performed. The results of this characterization are 
presented in section two. 
1. Web-based learning platform for comparative histology: 
The PATHPATH project 
1.1. Pilot course 
1.1.1. Recruitment of students 
In February 2013, 36 postgraduate students with at least masters’ degree in the 
medical or natural science field were enrolled from the partner universities. Eight 
students came from Germany, 11 from Finland, 16 from UK and 1 from Denmark. 
Their countries of origin were Denmark, Finland, Germany, Greece, Poland, 
Sweden, England, Scotland, Brazil, China, India, Iran and Pakistan. Twenty-four 
students had a natural science background (M.Sc., biochemistry or biology) and 
eight students had a medial background (MD). 32 students started the course. As 
the students’ backgrounds varied from medical to biochemical, they had high 
differences in background knowledge. Medical students were more comfortable in 
histology, but less in biomedical aspects as creation of genetically engineered mice 
and vice versa for biochemical students. Students had to fill in a questionnaire and 
wrote a short letter of motivation about their reasons for participating in the course. 
The motivation of most students’ was to deepen their knowledge about murine 
histology and background lesions of different mouse strains, as they were working 
on mouse projects.  
1.1.2. Content of the course 
The course content offered a composition of basic knowledge in mouse and human 
biology, biochemistry and histology, important for everyone working with mouse 
models of human diseases and in particular disease model pathologists. The content 
of the modules is displayed below. An examination at the end of each module tested 
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the learned knowledge of the students.  
1.1.2.1. Modules 
The pilot course was divided into the following specific modules: 
Module 1:  Basics in experimental animals and how to create genetically 
engineered mice 
Module 2:  Basic histology of different mouse strains: Webmicroscopy-self 
studying  
Module 3:  Basic histology of different mouse strains: exercises 
Module 4:  Mouse necropsy and sample collection  
Module 5:  Processing and staining of histological samples  
Module 6:  Description of the gross pathology  
Module 7:  Basic pathological lesions  
Module 8:  Histological description of neoplasms 
Final examination 
The collected material presented in the Moodle platform, included Webmicroscope 
slides, recorded lectures with voice-over technology including video clips, recorded 
interactive live lectures, discussion forums, learning exercises and material of the 
final examination. Figure 6 shows the timeline of the pilot course, outlining the time 
frames given to the students to complete each module and to finish the examination. 
Module 1 was prepared by the group of the University of Turku and covers 
principals of the creation of GEM. The group of the Technische Universität 
München (TUM) developed module 2 and 3. In particular, they cover the basic 
histology and histopathology of the commonly used mouse strains C57BL/6N and 
C57BL/6J (module 2) and BALB/cByJ, C3HeB/FeJ, 129P2/OlaHsd and FVB/NJ 
(module 3). These modules are described in detail under 1.1.2.2. Module 4 was 
covered by the group of the University of Glasgow and includes general guidelines 
for necropsy, sample collection and preparation of mice. Module 5 was developed 
by the groups of the Universities of Turku and Helsinki and covers the basic 
handling of histological samples. This includes tissue processing, embedding and 
histochemical and immunohistochemal stainings. The group of the University of 
Glasgow took care of module 6, which deals with gross pathology. Module 7 was 
prepared by TUM and deals with basic lesions in human and murine histopathology, 
described in detail under point 1.1.2.3. The group of the University of Glasgow 
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developed module 8; it covers principles in murine neoplasia. A final examination 
completed the course, which was held in July and August. Figure 6 gives a detail 
overview of the time table of the pilot course. 
 
Figure 6: Time bar with recruitment of the students and a timetable of the pilot course. WM 
(Webmicroscope).  
1.1.2.2. Module 2 and 3 
In module 2, histological descriptions and slides of the commonly used C57BL/6N 
and C57BL/6J mouse strains were available for self-studying. In module 3, the 
mouse strains BALB/cByJ, C3HeB/FeJ, 129P2/OlaHsd and FVB/NJ were 
introduced. The contents of module 2 and 3 could be used to complete the 
examination. Students accessed the link to the Webmicroscope via Moodle.  
1.1.2.2.1. Content module 2 
Here, students were able to examine extensively annotated histological slides 
stained with H&E from a male and female mouse. Each strain contains slides listed 
below. Aim of this module was to get all students familiar with the basic histology 
of a murine model and learn basic histologic expressions. Furthermore, physiologic 
correlations were explained and presented in the particular context.  
Brain 
Brain slides contain a section of the cerebrum, approximately at the high of 
diencephalon to mesencephalon and a section of the cerebellum or brain stem.  
Reproductive organs 
Module 2:
Basic 
histology of 
mouse strains: 
WM-self 
studying
15.4.-28.4.13
Februar March April May June July August
Recruitment 
of students
Deadline: 
28.2.13
Module 4: 
Mouse 
necropsy and 
sample 
collection
7.5.-19.5.13
Module 6: 
Description 
of gross 
pathology
27.5.-9.6.13
Module 8: 
Histological 
description of 
neoplasms
17.6.-30.6.13
Module 9: 
Final 
examination 2
20.8.13
Module 1: 
Experimental 
animals 
GM mice
15.4.-28.4.13
Module 3: 
Basic 
histology of 
mouse strains: 
WM-
exercises
29.4.-19.5.13
Module 7: 
Basic 
pathological 
lesions
3.6.-23.6.13
Module 5: 
Processing 
and staining 
histological 
samples
20.5.-26.5.13
Module 9: 
Final 
examination 1
17.7.13
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Slides of female reproductive organs include the ovaries, fallopian tube, uterus, 
cervix, vagina with fornices, ureter and urinary bladder. Slides of male mice include 
testis, epididymis, vas deferens, prostate, seminal vesicle, urethra and urinary 
bladder. 
Neck 
The sections of the neck contain trachea, esophagus, thyroid gland and parathyroid.  
Thoracic and abdominal organs 
This slide shows heart, lung, thymus, liver, spleen and kidney.  
Glands and lymph nodes 
This slide contains sections of the salivary glands, the adrenal glands and a lymph 
node.  
Gastrointestinal tract and skin 
This section contains the forestomach with limiting ridge and the glandular 
stomach, sections of small and large intestine, pancreas and skin.  
In general, relevant structures of these sections were annotated, as well as artifacts 
and pathological abnormalities. Figure 7 indicates an example of an annotation of 
normal histology.  
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Figure 7: Tissue slide with annotations A: Complete slide with annotations on the right side, B: 
Annotation of normal liver tissue. 
1.1.2.2.2. Content module 3 
In this module, in addition to the mouse strains of module 2, BALB/cByJ, 
C3HeB/FeJ, 129P2/OlaHsd and FVB/NJ mouse strains are presented. The focus of 
this module was to point out differences in background lesions between the 
different mouse strains as well as differences between female and male mice and 
the similarities and differences to human histology. Furthermore, physiologic 
correlations were presented and discussed. Whenever possible, age-related lesions 
were included. Figure 8 show annotated examples of different background lesions 
A
B
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in the mouse strains; Table 3 gives an overview of background lesions. 
 
Figure 8: A: Annotation of dystrophic cardiac calcification in a female BALB/cByJ mouse, B: 
Annotation of accessory cortical node and subcapsular cell hyperplasia in a female C57BL/N mouse.  
  
B
A
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Table 3: Background lesions and gender differences in strains presented in modules 2 and 3 (Serpi 
and others 2013). 
1.1.2.2.3. Examination module 2 and 3 
For evaluation of the student’s learning progress, short tests had been prepared. 
They included 19 questions, which had to be answered by annotating a picture taken 
by the students themselves (part I, questions 1-19) and four open questions (part II, 
questions 20-23). In part I, students had to recapitulate their learned knowledge 
about normal histological structures of organs, physiological context, background 
lesions in mice and gender differences in mouse strains. The didactic goal was to 
make them familiar with histological and pathohistological structures. Part II 
challenged the students to utilize their new knowledge use-oriented. For instance, 
they had to discuss why they should use a certain background strain for a clearly 
defined project and avoid other strains. Figure 9 shows an example of each type of 
Strain Lymphoid organs Heart Adrenal glands Corpus callosum Liver Pancreas
C57BL/6J
- -
Female: no fat cells at all,
instead area of increased 
vascularization between 
cortex and medulla
subcapsular cell 
hyperplasia
-
Small non-
specific infiltrates
-
C3HeB/FeJ Better developed 
lymphoid organs
- Peyer's patches 
intestine 
- BALT
- B-cell marginal zone 
spleen
- extramedullary 
hematopoesis in spleen 
(erys, megakaryocytes)
-
Female: rare fat cells 
between 
cortex and medulla
increased vascularization 
area less conspicious
subcapsular cell 
hyperplasia
male: subcapsular cell 
hyperplasia
-
Rarely infiltrates
increased number 
of necrotic foci 
Lipomatosis
Balb/cAnPt
-
Male: 
calcifications in 
epicardium
Female: fat 
cell zone between cortex 
and 
medulla
increased vascularization 
area not existing
-
Rarely infiltrates
-
S129/J
- -
Female: rare fat cells 
between 
cortex and medulla
increased vascularization 
area less conspicious
no subcapsular cell 
hyperplasia
Without corpus callosum Rarely infiltrates
-
BALB/cByJ Female: BALT,
peyer's patches
Epicardial 
calcifications
Subcapsular cell 
hyperplasia
Without corpus callosum Male: liver 
steatosis -
C57BL6/Ntac
- -
Female: subcapsular cell 
hyperplasia
- - -
129P2/OlaHsd
- -
No subcapsular cell 
hyperplasia
- - -
FVB/N
- - - -
Female: multifocal 
hepatocellular 
necrosis
Lipomatosis
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question. Students were allowed to use the course material to answer the questions. 
Detailed solution to the questions were provided afterwards. Additionally, students 
received a personal feedback about their positive results and explanation of their 
mistakes.  
 
Figure 9: Examples for questions to module 2 and 3. The examination tests the knowledge of the 
students in terms of murine basic histology and histopathology, differences between mouse strains 
and differences to human histology. Answers were provided after the deadline.  
1.1.2.3. Module 7 
Module 7 covers basic pathological lesions in humans and mice. Before assessing 
the Webmicroscope slides, students had to listen to a module related lecture 
consisting of PowerPoint-presentations with voice-over. To facilitate this module, 
the content was split in two parts, as indicated below, ending with an examination.  
1.1.2.3.1. Content module 7 
The content of module 7 covered the following topics: Cell adaptations, cell injury 
and death, as well as inflammation and tissue repair. The module started with a 
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lecture about cell adaptations and cell injury with corresponding virtual human and 
murine tissue sections. The questions for the examination were released two days 
later. The second lecture about inflammation and tissue repair was opened one week 
later and virtual slides were provided. The second part of the questions was 
available two days after opening of the lecture. 
Figure 10 depicts an example of comparative lesions in mouse and human.  
 
Figure 10: Example of murine (A) and human (B) acute pancreatitis. The murine pancreatitis can be 
classified as interstitial, meanwhile the human pancreatitis is a necrotizing pancreatitis. 
1.1.2.3.2. Examination module 7 
For every subtopic of the module, three question were prepared. The first questions 
covered theoretical knowledge about general pathology, e.g. a definition of 
A
B
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metaplasia. The second and third question were covering human and murine 
pathohistology. As in the previous pathohistology modules, students had to 
annotate slides and compared the lesions seen in human and murine tissue.   
1.1.3. Final examination 
The final test was held twice 3 and 4 months after the beginning of the pilot course. 
Questions about histology topics were similar to questions prepared in modules 2, 
3 and 7. The test included eight interactive questions, one question per module. A 
maximum of 24 points was reachable and most students performed very well. Out 
of 21 participating students, 20 passed the exam, one student needed a second try. 
Figure 11 shows an example of the final examination.  
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Figure 11: Final examination of the Pilot Course. 
1.1.4. Collection of students’ feedback 
The Pilot Course was advertised and started with 32 students of whom 21 finished 
the course successfully. After completion of the course, students were asked to fill 
in a feedback-sheet, which 18 students completed. Feedback was collected as 
points, ranging from 0 to 5.0 points, with 5.0 points being the highest score. This 
grading schema was used, as it was already successfully implemented at the 
University of Helsinki, Finland 
(http://www.helsinki.fi/law/studies/general/credits_grading.html) [date: 
01.10.2014].  
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Generally, the students rated the course in average with 4.2 points, and with 4.5 
points as the course being useful for their work. In addition, there was a significant 
improvement of students’ knowledge in murine pathology (32 %); students rated 
themselves before the course in average with 2.3 points and after the course with 
3.9 points. Figure 12 shows a part of the students’ feedback questionnaire.  
 
Figure 12: Students evaluation on the course in general 
Concerning module 2 and 3, the average of points was > 4.0 points, except for the 
time given to finish module 3 (3.7 points). Importantly, the students gave high 
points for quality of the content (4.5 and 4.3 points) and usefulness of exercises (4.3 
and 4.6 points), see Figure 13.  
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Figure 13: Students’ evaluation of module 2 and 3 
As in modules 2 and 3, students’ rating of module 7 was > 4.0 points, with the 
exception of the allocated time (3.6 points). Here, as well the quality of the content 
(4.2 points) and the usefulness (4.4 points) was rated high, indicated in Figure 14. 
 
Figure 14: Students’ evaluation of module 7 
Asked for their interest in participating in a comparative, human-mouse organ-
specific course out of 18 students 17 answered with positively (94 %).  
An open text form was also provided in the feedback catalogue, asking the students 
for the most relevant issue concerning the course, many students answered that the 
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histology part was most useful for them. Examples for students’ comments were: 
“Basic histology as well as pathological lesions and their description were most 
relevant to me. The other modules also added some new information to my 
preexisting knowledge.” 
“I learned a lot about microscopical structure of different organs, and that there 
are differences between mouse strains. Also, the description of the neoplasms I 
found very useful.” 
“For me it was most important to learn about mouse histology and the analysis of 
histological samples to help me with my future analysis of my models. This course 
has covered this in great detail and has very much helped me to improve my 
approach of histological analysis from start (organ collection) to finish (staining 
and analysis) as it covers every aspect during this process as well as the initial 
development of mouse models.” 
As already seen in the general evaluation, the biggest issue students had with the 
course, was the time allocated with the different modules: 
“The only issue for me was the time allotted for each module” 
1.1.5. Differences between medical or natural science students 
As previously reported, students had differences in background and therefore not 
the same basic knowledge about pathohistology. After the final examination, 
students were grouped into natural science background and medical background. 
Even though natural science students performed very well in the pathohistology 
part (mean of correct answers: 87 %), the medical students showed in significantly 
average higher points (mean of correct answers: 97 %, p-value < 0.05). 
Additionally, medical students had more often full marks. In general, medical 
students showed more consistent results, meanwhile students with a natural science 
background differed in the group itself. Figure 15 shows the differences in marks 
between medical and natural science students. 
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Figure 15: Differences in background between natural science students and medical students. A: 
Medical students achieved higher points in the pathohistology part of the final examination. The 
maximum of points was 12. B: Medical students reached more often full marks than natural science 
students did.  
1.1.6. Dissemination and exploitation strategy and activities 
Information about the course was available on a public website, which had been 
created for the project (http://pathpath.eu/). The course content was advertised 
during a poster and various talks in international congresses (Haneder and others 
2013, Haneder and others 2014, J.C. Patterson-Kane and others 2013, Strauss and 
others 2013).  
2. PDAC and TNC 
2.1. Practical application of the course: PDAC project  
Together with the feedback collected from the students, the PDAC project was used 
to evaluate the course content. After the successful run of the pilot course, the 
morphological characterization of a genetically engineered mouse model for 
pancreatic cancer with a depletion of the stromal protein TNC was conducted. The 
results are presented and the usefulness of the course for the mouse project is 
discussed below.  
2.2. TNC expression in KC mice 
In human PDAC tissue, immunohistochemistry reveals a selective stromal 
accumulation of TNC (Esposito and others 2006). To validate whether the same is 
true for murine precursors of PDAC and murine PDAC, pancreata of KC mice were 
stained for expression of TNC. A moderate to intense accumulation of stromal TNC 
can be observed around ductal lesions in areas of ADM, murine PanIN lesions 
(Figure 16) as well as in the invasive front of murine PDAC, thus confirming the 
selective expression of the Tnc gene in the mouse model.  
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Figure 16: A: A KC mouse mimicking human precursor lesion of PDAC. Areas of ADM (arrows) 
and murine PanIN-1 lesions (arrowhead) are present next to unaffected acinar areas (asterisk), 5x, 
HE, B: Immunohistochemistry with an antibody against TNC on pancreatic tissue of a KC mouse. 
Pronounced expression of TNC (brown DAB stain, arrows) around ductular lesions in areas of 
ADM, 10x.  
2.3. Architectural distortion and classification of precursor lesions 
To assess the influence of an absence of TNC protein on the development of murine 
pancreatic precursor lesions, triple mutant mice lacking TNC were generated. This 
was performed by crossbreeding TNC null mice with KC mice, both on a C57BL6N 
background, to achieve KC-TNChet and KC-TNCko mice. KC-TNChet and KC-
TNCko mice were smaller than their TNC bearing littermates and more prone to 
biting by their siblings, as seen on their fur and adnexa and were found more often 
dead in their cages. HE stained serial sections of pancreata of KC, KC-TNChet and 
KC-TNCko mice were evaluated semi-quantitatively in different age groups, 
ranging from one to 15 months (1 month, 2 months, 3 months, 6 months, 9 months 
and 12-15 months), including appropriate controls. At least four animals per group 
were analyzed. KC mice alone develop the complete spectrum of precursor lesions 
as well as invasive PDAC (Hingorani and others 2003). Diseased pancreata of TNC 
knockouts and KC mice were compared and architectural distortion of pancreata as 
well as the number and type of precursor lesions and frequency, histological 
subtype and grading of PDACs was calculated. In addition, murine AFL were 
counted (Aichler and others 2012). Figure 17 shows precursor lesions of PDAC that 
develop in KC mice, but also TNC mutant mice. Control animals did not show any 
phenotype in their pancreatic sections.  
 
A B
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Altogether, 106 mutant mice with the following genotypes 
KC-TNCko   n=28 
KC-TNChet   n=46 
KC    n=32 
were used for histopathological evaluation.  
 
 
Figure 17: A: Murine PanIN-1 lesion, with basally oriented nuclei and mucinous cytoplasm (arrows) 
A B
C E
D
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next to an unaffected duct (asterisk) in a KC-TNCko mouse, 20x; B: murine PanIN-2 lesion, with 
nuclear stratification (arrow) in a KC-TNCko mouse, 20x; C: murine PanIN-3 lesions, with marked 
nuclear atypia, loss of basal orientation of nuclei (arrow) and budding of cells in the lumen (asterisk) 
in a KC-TNCko mouse, 20x; D: area of ADM with TCs (arrow) and MTCs (asterisk) in a KC-TNCko 
mouse, 10x; E: murine AFL with flat cells (arrow), a ductal-like morphology and the typical onion 
shaped stroma surrounding the lesion (asterisk) in a KC-TNCko mouse, 40x 
 
2.3.1. One month-old mice 
Mutant pancreata belonging to the group of one month-old mice showed beginning 
areas with acinar-ductal metaplasia and invasion of inflammatory cells, mainly 
lymphocytes and plasma cells. In small tissue areas, the acinar cells formed luminal 
spaces and changed their morphology to a more ductal like phenotype with cuboidal 
cells. Mucinous tubular complexes, ductal lesions with mucin containing columnar 
cells were distributed within areas of ADM. These lesions are morphologically not 
distinguishable from PanIN-1 lesions. PanIN-1 lesions were a rare finding, and 
were not connected to a specific phenotype. Single AFL lesions were already 
present in some mice at the age of one month. No differences of number of AFL 
between all phenotypes could be observed. All mice exhibited only few lesions, 
which accounted for less than 5 % of the pancreatic tissue. Control animals did not 
show any morphological alteration in pancreatic tissue (Figure 18 at 2.2.3.).  
2.3.2. Two months-old mice 
Compared to the group of one month, pancreata show a more pronounced 
architectural distortion (ranging von 10 % to 20 %) with formation of ADM areas 
containing TCs and MTCs, a distinct inflammatory reaction and fibrosis. PanIN-1 
lesions also increased in number. Animals belonging to group KC-TNChet and KC-
TNCko showed a slightly higher percentage of architectural distortion compared to 
KC mice, even if not significant (Figure 18 at 2.2.3.).  
2.3.3. Three months old mice 
Here, distinct differences between genotypes were readily apparent. This age group 
was therefore chosen for further analyses.  
Mutant pancreata showed a pronounced architectural distortion with AFL and 
PanIN-1 as well as PanIN-2 formation. One animal belonging to the KC-TNCko 
displayed a PanIN-3 lesion. As in two months-old animals, mice belonging to group 
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KC-TNChet and KC-TNCko showed a slightly higher mean percentage of 
architectural distortion compared to KC mice (Figure 18).  
 
Figure 18: A: Mutant pancreata of three months old mice, A, D: Representative pancreas of a KC 
mouse, B, E: KC-TNChet, C, F: KC-TNCko. Murine pancreata show loss of acinar parenchyma and 
architectural distortion (asterisks), PanIN (arrowheads) and AFL (arrows) formation. Architectural 
distortion is more pronounced in KC-TNChet and KC-TNCko mice; A-C: 2x, D-F: 5x; G: 
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Architectural distortion of pancreatic of young animals bearing precursor lesions of PDAC. 
Compared to KC mice, KC-TNChet and KC-TNCko mice display a higher architectural distortion. 
H: Comparison of mutant animals of age group three months. 
2.3.4. Six months-old mice 
Mice of all genotypes exhibit around 70 % architectural distorted tissue with 
extended areas of ADM containing AFL, TCs and MTs and a lymphoplasmacellular 
inflammatory cell infiltrate. Many PanIN-1 and PanIN-2 were detectable in all 
genotypes, as well as one PanIN-3 lesion in an animal belonging to the KC-TNCko 
group. At this time point, there was a high degree of architectural distortion in all 
groups and no difference could be identified. 
2.3.5. Nine months-old mice 
Similar to 6 months old mice, all mutant mice displayed an architectural distortion 
of about 95% of the tissue with fibrosis, PanIN-1 and PanIN-2 and AFL. PanIN-3 
were detected in mice of the KC-TNChet and KC-TNCko group and one mouse of 
the KC-TNChet group developed PDAC with invasion in the stomach and liver 
metastases. The tumor consists of densely packed, moderately differentiated 
glandular structures surrounded by a desmoplastic stromal reaction. The tumor 
showed a central necrotic area with infiltration of neutrophil granulocytes.  
2.3.6. Twelve to fifteen months-old mice 
As in nine months-old mice, all mutant mice displayed an architectural distortion 
of at least 95% with fibrosis, PanIN-1 and PanIN-2 and AFL. PanIN-3 were 
observed in all groups and some animals developed metastatic PDAC. PDAC was 
twice as frequent in KC-TNCko and KC-TNChet as in KC mice at the age of 12 
months, as shown in Figure 19.  
 
Figure 19: PDAC in mutant mice. At the age of 12 months, more KC-TNChet and KC-TNCko mice 
0
20
40
60
80
tu
m
o
rs
in
 1
2
 m
o
s
o
ld
m
ci
e
[%
]
WT KC KC-TNChet KC-TNCko
0
5
10
15
20
25
tu
m
o
rs
in
 a
ll
 a
g
e
g
ro
u
p
s
[%
]
WT KC KC-TNChet KC-TNCko
A B
IV. Results     57 
harbor PDAC than KC mice.  
2.4. Fibrosis in mutant pancreata 
Additionally to the progression of precursor lesions, an increasing fibrosis 
accompanied tumor development. To validate and further characterize the 
observations, Masson Goldner trichrome and Movat stains were performed in 3 
months-old mice and quantified as described in Methods. In the Masson Goldner 
stain, the pattern of fibrotic deposition was similar in all groups and mostly 
displayed a perilobular and perilesional (i.e. around ADM/precursor lesions) 
distribution. Mice of the KC-TNChet and KC-TNCko groups showed a higher 
percentage of fibrosis (17.4 % and 18.2 %, respectively) when compared with the 
KC group (12.7 %). The difference between the KC and KC-TNChet group at the 
age of three months was significant (p-values KC-TNCko to WT < 0.01, KC-
TNChet to WT < 0.01, KC to WT < 0.01; KC-TNCko to KC 1.45 and KC-TNChet 
to KC < 0.05 respectively). Figure 20 shows representative pictures of mice at the 
age of three months. 
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Figure 20: Masson Goldner stain of mutant mice at the age of three months, A: KC mouse with red 
stained residual acinar tissue and islets and green fibrotic area, 5x, B KC-TNChet mouse with 
perilobular and perilesional accumulation of fibrotic tissue, 5x C: KC-TNCko mouse with widely 
remodeled tissue, 5x, D: Calculation of fibrotic areas in pancreata of wild type and mutant mice at 
the age of three months. KC mice show less fibrotic areas when compared to KC-TNChet and KC-
TNCko mice. 
With the Movat pentachrome stain immature connective tissue stains blue due to 
the high content in mucopolysaccharides, whereas older fibrotic lesions, containing 
mature collagens, are stained yellow (Doello 2014). In general, in beginning ADM 
lesions, a blue colored layer of mucopolysaccharides containing extracellular 
matrix encircled remodeled acinar parenchyma, and more advanced lesions with 
TCs, MTCs and AFL are surrounded by mature collagen. This could be observed 
in animals of all genotypes. Interestingly, in KC-TNChet and KC-TNCko mice, an 
earlier switch to the mature fibrotic tissue could be observed, as depicted in Figure 
21. As already seen in the Masson Goldner stain, Movat’s stain underscored the 
tendency of animals lacking TNC towards a more fibrous phenotype. 
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Figure 21: A: Mutant pancreata of a KC animal, stained with Movat stain, 10x, B: Mutant pancreata 
of a KC-TNChet animal, stained with Movat stain, 10x, C: Mutant pancreata of a KC-TNCko animal, 
stained with Movat stain, 10x, white arrow pointing to blue colored layer of mucopolysaccharides, 
black arrow shows mature collagens with a yellow color; D: Result of Movat stained mutant 
pancreata compared to control animals at the age of three months, results as mean values and SEM. 
All mutant mice show a clearly higher percentage of fibrotic tissue when compared to WT animals. 
As in Masson Goldner stain, there is a tendency towards a higher percentage of fibrosis in KC-
TNChet and KC-TNCko animals. 
2.5.  Mucin 
As the previous stains revealed an influence of TNC on the architectural distortion 
of mutant pancreata, further stains were used to assess the lack of TNC on 
precancerous lesion development. In order to check the influence of the prevalence 
or absence of TNC on the development and character of mucinous lesion, mucin 
staining was used. Cytoplasmic mucin content of PanINs and MTCs can be 
highlighted by Alcian blue stain and PAS reaction (Muller-Decker and others 
2006). The apical mucinous cytoplasm within the lesions stains violet to blue, 
depending on the pH of the containing mucin. Computer aided analysis was used 
to calculate mucin content, and results are stated as percentage of mucin to 
completely pancreatic tissue area. In comparison to KC mice, KC-TNChet and KC-
TNCko mice show a slightly higher percentage of mucinous containing structures 
(Figure 22). The staining pattern was comparable in all groups. 
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Figure 22: Computer aided calculation of mucin containing lesions, mice at the age of three months. 
A: KC mouse, 5x; B: KC-TNChet mouse, 5x; C: KC-TNCko mouse, 5x; D: KC-TNChet and KC-
TNCko mice show a higher content of mucinous lesions compared to KC mice. 
2.6. Ductular structures and PanIN 
The impact of TNC on the development of tubular structures, independently from 
the mucin content, was further assessed by CK19 staining. Normal ducts, PanIN, 
TCs, MTCs and AFL were all positive for CK19, as expected; acinar cells and islets 
were negative (Aichler and others 2012). In comparison to KC mice, KC-TNChet 
and KC-TNCko mice showed a significantly higher percentage of ductular 
structures, as depicted in Figure 23 (p-values KC-TNCko to WT < 0.01, KC-TNChet 
to WT < 0.01, KC to WT < 0.01; KC-TNCko to KC 0.03 and KC-TNChet to KC 0.05 
respectively). 
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Figure 23: Ductular structures, assessed by CK19 stain, mice at the age of three months. A: KC 
mouse 5x; B: KC-TNChet, 5x; C: KC-TNCko, 5x, all diseased (arrows) and normal (arrowheads) 
ductular structures are detected by CK19 staining; C: Compared to KC mice, KC-TNChet and KC-
TNCko mice show a higher percentage of ductular structures.  
MTC and PanIN were further assessed by Claudin18 (CLN-18) immunoreactivity.  
All murine PanIN-1 to PanIN-3 and MTCs showed strong membranous staining for 
CLN-18, as expected. Here, the KC-TNCko group showed a higher rate of PanIN 
when compared to the KC-TNChet and KC groups at the age of three months, as 
shown in Figure 24 (p-values KC-TNCko to KC 0.13 and KC-TNChet to KC < 0.01 
respectively). 
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Figure 24: Assessment of ductular structures with CLN-18 staining in the age group of three months. 
A: KC mouse with membranous CLN-18 positivity (arrows), 5x; B: KC-TNChet, 5x; C: KC-TNCko, 
5x; D: KC-TNChet animals show slightly more CLN-18 expression, meanwhile KC-TNCko animals 
exhibit significantly more diseased structures than KC animals at the age of three months.   
2.7. Proliferation and apoptosis  
In order to assess if the described differences in the frequency of ductular structures 
and precursor lesions was related to differences in cell proliferation or 
apoptosis/senescence, staining for Ki67, cleaved caspase-3 and p16 were performed 
and semi-quantitatively assessed. 
In general, areas of ADM showed an increased number of Ki67-positive cells when 
compared to normal acinar parenchyma. AFL lesions could be easily detected by 
their high expression of Ki67-antigen, underscoring their highly proliferative 
nature. In contrast, PanIN-1 lesions exhibited only few Ki67 positive cells (see 
Figure 25). Interestingly, in areas of ADM, mice belonging to the KC-TNCko and 
KC-TNChet groups showed significantly higher proliferative indices than those of 
the KC group (p-values KC-TNCko to KC < 0.01 and KC-TNChet to KC 0.01 
respectively). In AFL, PanIN-1 and PanIN-2 lesions, no differences between the 
genotypes could be detected. 
Only a small number of apoptotic cells were detected by cleaved-caspase 3 stain. 
In areas of ADM, few apoptotic cells were present with high differences between 
mice of the single groups so that no differences in genotypes were found. AFL and 
PanIN-1 lesion contained hardly any apoptotic cells; therefore, no differences in 
genotypes could be observed (Figure 26).  
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Figure 25: Calculation of proliferation of lesions in areas of ADM, mice at the age of three months, 
A: KC mouse with proliferating cells in areas of ADM (arrow), a low proliferation index in PanIN-
1 lesions (arrowhead) and high proliferation in AFL (asterisks), 5x, inset with nuclear details in areas 
of ADM, 20x; B: KC-TNChet mouse with highly proliferating cells in an area of ADM (arrows) and 
low proliferation in PanIN-1s (arrowhead), 5x, inset with nuclear details in areas of ADM, 20x; C:  
KC-TNCko mouse with highly proliferating cells in ADMs (arrows) and AFL (asterisk), low 
proliferation in PanIN-1s (arrowhead), 5x, inset with nuclear details in areas of ADM, 20x; D: 
Compared to KC mice, KC-TNChet and KC-TNCko mice at the age of three months exhibit a 
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significantly higher proliferation activity. 
IV. Results     71 
 
A
B
C
IV. Results     72 
Figure 26: Representative pictures of mutant pancreata with apoptotic cells, pancreata of mice at the 
age of three months A: KC, B: KC-TNChet, C: KC-TNCko mice, 20x, arrows pointing to apoptotic 
cells in areas of ADM adjacent to not affected acinar parenchyma. 
All genotypes showed an accumulation of p16 protein in nuclei of epithelia in ADM 
areas and PanIN lesions, indicating an upregulation of Cdkn2a, most likely related 
to increased proliferation. AFL lesions showed a reduced intensity of the nuclear 
staining, and a slight cytoplasmic staining, as previously observed. Taken together, 
when compared to each other, no obvious differences in the genotypes could be 
detected at the age of three months (Figure 27).  
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Figure 27: Representative pictures of mutant pancreata with p16 accumulating cells, pancreata of 
mice at the age of three months, A: KC, B: KC-TNChet, C: KC-TNCko mice, 5x, insets with 20x, D: 
AFL in a KC-TNCko mouse with light nuclear positivity. 
2.8. Wnt signaling pathway 
Since TNC and proteins of the Wnt signaling pathway are known to interact during 
developmental processes and cancer (Hendaoui and others 2014, Saupe and others 
2013), the expression of E-cadherin and β-catenin was investigated. In all 
genotypes, all normal and diseased structures display a membranous staining of E-
cadherin and β-catenin with the exception of PDAC. Here a loss of E-cadherin and 
β-catenin was observed in some of the cancer cells. However, the absence of TNC 
did not to influence the expression of these proteins (Figure 28).  
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Figure 28: Absence of TNC does not influence the expression of β-catenin and E-Cadherin in mice 
at the age of three months. A: membranous expression of β-catenin and D: E-Cadherin in a KC 
mouse, B, E: in a KC-TNChet mouse, C, F: in a KC-TNCko mouse, all 5x, G: partial loss and lower 
staining intensity of E-Cadherin expression in mouse bearing PDAC, 10x.  
2.9. NOTCH/HES1 signaling pathway 
2.9.1. NOTCH2 
Finally, due to the known role of the Notch pathway in ADM and given the 
significant differences observed in the extension of ductular structures between the 
groups, the expression of NOTCH2 and its downstream protein HES1 were 
investigated. For NOTCH2 staining, normal ductal epithelium and centroacinar 
cells served as an internal control. Unaffected acini and islets were negative for 
NOTCH2 staining. In all genotypes, in areas of ADM more than 50% of nuclei were 
positive for NOTCH2 protein. Similar results could be observed for PanIN-1 
lesions. Interestingly, AFL lesions showed a weaker nuclear staining with less 
positive cells. No differences in NOTCH2 expression between the genotypes could 
be observed (Figure 29). 
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Figure 29: Nuclear and cytoplasmic NOTCH2 expression of PanIN, ADM, AFL lesions and 
centroacinar cells in mice at the age of three months, A: KC mouse, 5x, B: KC-TNChet, 5,  C: KC-
TNCko, 5x, D: KC-TNCko mouse with unaffected acinar parenchyma, arrows pointing to small, 
nuclear NOTCH2 positive ducts, arrowheads indicating nuclear positivity in centroacinar cells, 20x, 
E: KC-TNCko mouse with nuclear NOTCH2 positive duct with arising PanIN-1 (asterisk), 20x, F: 
KC-TNCko mouse with NOTCH2 positive nuclei in areas of ADM (white arrow) and weak nuclear 
positivity in AFL (black arrow), 20x.  
Centroacinar cells served as an internal control for HES1 staining. Ductular cells, 
acini and islets were negative for HES1. In all genotypes at the age of three months, 
in areas of ADM more than 50 % of nuclei were positive for HES1 protein. Similar 
results could be observed for PanIN-1 lesions. Interestingly, AFL lesions showed a 
weaker nuclear staining with less positive cells. In concordance to NOTCH2 
expression, no differences between genotypes can be observed in the expression of 
HES1 (Figure 30).  
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Figure 30: Nuclear HES1 expression of PanIN, ADM, AFL lesions and centroacinar cells in mice at 
the age of three months, A: KC mouse, 5x, B: KC-TNChet, 5x, C: KC-TNCko, 5x, D: KC-TNCko 
mouse with unaffected acinar parenchyma, arrows pointing to small, HES1 negative ducts, 
arrowheads indicating nuclear positivity in centroacinar cells, which served as internal positive 
control 20x, E: KC-TNCko mouse with nuclear HES1 positive PanIN-1 cells (asterisk), 20x, F: KC-
TNCko mouse with HES1 positive nuclei in areas of ADM (white arrow) and weak nuclear positivity 
in AFL (black arrow), 20x. 
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V. DISCUSSION 
1. The PATHPATH project 
This project was conducted since several studies revealed a great need of trained 
researchers in the area of comparative pathology (Barthold and others 2007, Cardiff 
and others 2008, Sundberg and others 2012). The great interest in the training 
course underscores the need for a training that educates specialists in histopathology 
of animal models as well as in human pathology. In addition to the development of 
the training course, the project aimed also to strengthen the collaboration at the 
European level in the field of disease model pathology, and thereby enhanced the 
quality of education and possibilities for student exchange.  
A web-course offers the possibility to reach many students all over the world, 
although in this project the pilot course was restricted to a European level due to 
the rather tight time frame. Our training program has clearly shown that e-learning 
is an optimal setting for the distribution of knowledge over wide distances and to a 
large number of students at the same time. This is consistent with previously 
reported experiences (Ruf and others 2008). Interestingly, Ruf and others identified 
the lack of a prompt availability of other students and teachers as a disadvantage of 
the e-learning (Ruf and others 2008). However, this was not identified as a problem 
in the present project. By using live lectures, chat functions, discussion forums and 
availability of teachers per mail, a good level of interaction was achieved. 
Moreover, as students had the possibility to upload descriptions or questions about 
their own mouse models and get feed-back both from the teachers and from other 
students, a team-spirit was created. Many students used the possibility to ask 
questions per mail or discussed their problems in the chat function. Actually, this 
indirect interaction offers the students the chance to think over their questions and 
better reflect their problems. However, a rapid communication between teachers 
and students is necessary in order to promptly solve problems and constructive 
feed-back of the students' performance should be also delivered fast (McKimm and 
others 2003). A commitment of the teachers to be reachable and available at least 
at defined time points and, on the other side,  the self-discipline of the students are 
fundamental elements for the success of a web-based learning environment. The 
traditional learning is usually pre-structured, but the web-based learning improves 
VI. Discussion       85 
the capability of self-organizing in students (Masic 2008). Web-based learning can 
be therefore offered as the solely learning platform to more experienced, post-
graduate students, meanwhile it could integrate traditional learning methods for pre-
graduate students (Masic 2008). Since only post-graduate students were included 
in our course, we can confirm the suitability of web-based learning for this type of 
audience. 
An important issue in a web-based program is the need for broadband access and 
the associated costs (Parisky and Boulay 2013). Slow internet connection impairs 
e-learning, as long downloading-times are frustrating (Masic 2008). Many students 
claimed that they had only limited time to complete the course while working and 
time-consuming internet problems would have been a major problem. Costs are 
another negative factor, as all students need a computer that is able to process the 
images uploaded in the Webmicroscope. As technology is continuously and rapidly 
advancing in many countries, it seems likely that these problems can be overcome. 
1.1. Evaluation of the pilot course 
As shown by the students’ feed-back, the pilot course ran very successfully. The 
rating system of the different parts of the feedback forms was very helpful to assess 
specific aspects; the anonymous free text evaluation was also very helpful, since 
students freely wrote their subjective positive and negative opinions about the 
course.  
Nevertheless, several issues were identified during the pilot course. An important 
aspect, which was underscored both by students and by teachers was the differences 
in education and training of the students. In particular, students with medical 
background need less guidance and support in histopathology than student with 
biochemical background. There is therefore the necessity to clearly define the 
scopes of the course, but also the pre-requisites to attend it. In order to achieve a 
larger audience, a possibility would be to split the course in two levels (gene-
modified topics plus modeling and normal histology), depending on the education 
level and background of the students. At the beginning of the course, students had 
to fill in a questionnaire and write a motivation letter. The data gained from this 
approach offer a good possibility to structure the course more appropriately 
according to the background and training level of applicants.  
Another general complaint was the time dedicated to each module. This aspect 
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certainly depends on the work pace of the single student, as well as on the individual 
knowledge. Nevertheless, more time should be considered in a regular course, as 
many students choose e-learning platforms so that they can attend them along with 
normal work. 
1.2. Discussion of tools used in the course 
Several didactical tools have been used in the pilot course. A major advantage of 
this course was the use of the Webmicroscope, as students could examine slides 
using tools normally present in a standard microscope, which is by far more 
informative than a static picture in a book. Szymas and others could observe similar 
findings in five years of dental education with a Webmicroscope (Szymas and 
Lundin 2011). As discussed before, live lectures, chat functions, discussion forms 
and availability of teachers per mail were the tools to create an environment similar 
to traditional teaching. In this respect, two observations could be made: students did 
not like to discuss when they had to (that is, within the frame of pre-programmed 
discussion forums) and rather engaged in spontaneous chats to solve specific 
problems. For instance, they discussed the solutions of the gross morphology 
module, as some students were less experienced in this topic than others.  Therefore, 
the possibility to discuss via a chat function is highly recommended in a web-based 
course. Furthermore, it is important that a teacher is leading the conversation in the 
background and is available when needed. Another interesting point was that 
students preferred voice-overed lectures, which were always available, to live-
lectures, where they had the possibility to ask questions and get live answers 
through direct interaction with the teacher. The most likely explanation is that 
students preferred to organize the learning process according to their own schedule 
and have the possibility to reflect on questions, which were then asked via email. 
Therefore, in our experience, a live lecture is not a mandatory tool in a web-based 
training course.  
1.3. Outlook 
The implementation of this course in the routine education of scientific researchers 
working with mice should be achieved. A possible setting would be the 
participation of other universities in order to create a European or even global 
network for training in disease modeling.  
Such a training program can improve the quality of translational medicine and 
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achieve a more efficient and ethical use of experimental animals.  
2. PDAC and TNC 
In the second part of the project I aimed at showing an example of practical 
application of the knowledge gained by attending the course in disease modeling. 
Here I focused on the role of TNC, a stromal glycoprotein, in the development of 
precursor lesions and subsequent desmoplasia in pancreatic carcinogenesis. TNC is 
upregulated in PanIN progression to invasive PDAC, indicating a central role of 
this protein in cancer development (Paron and others 2011). The deposition of 
extracellular TNC in KC mice was found to be similar to the previous described 
human situation (Esposito and others 2006).  
2.1. Influence of TNC on PDAC and its precursor lesions. 
To assess the influence of an ablation of TNC on the development of precancerous 
lesions, TNC mutant mice on a C57BL6/N background were used. The focus of this 
study was set on young mice at the age of three months, as these mice show low-
grade precursor lesions, which then progress to higher advanced lesions. As 
previously stated, the role of the stromal reaction in PDAC is still being 
controversial discussed (Gore and Korc 2014) and no data are available about the 
relevance of the stromal reaction at the preinvasive stage. 
The higher percentage of architectural distortion and more pronounced 
development of PanIN lesions found in KC-TNChet and KC-TNCko mice compared 
to KC mice seem to suggest a protective role of TNC for KRASG12D-targeted 
epithelial cells. The known interactions between TNC and epithelial cells via 
indirect pathways activation of transmembrane receptor proteins (e.g. integrins) or 
via the cytoskeleton (Brellier and Chiquet-Ehrismann 2012) could represent the 
basis for this function of TNC. In addition, this apparent tumor-preventing role of 
stromal TNC in early precursor lesions indicates that the stroma reaction itself 
cannot be seen only as tumor promoting, as suggested by others. For example, it 
has been recently shown that by knocking out the sonic hedgehog pathway in a 
mouse model of PDAC and thereby targeting the desmoplastic stroma, a higher rate 
of ADM areas and PanIN lesions is observed in Shhfl/fl;Pdx1-Cre;KrasLSL-
G12D/+;p53fl/+;Rosa26LSL-YFP (ShhPKCY) mice when compared to control animals 
(Rhim and others 2014). These results raise the question if one underestimates the 
several functions of the desmoplastic stromal components - seemingly not only in 
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tumor support but tumor prevention (Rhim and others 2014). Özdemir and others 
observed a similar phenomenon, as conditionally abrogated α-SMA induced 
comparable effects, favoring the hypothesis that the desmoplastic stroma protects 
against rather than accelerates PDAC development (Ozdemir and others 2014). 
Taken together, these results support the concept that the tumor stroma with its 
extracellular components might not only be the driver of tumorigenesis in PDAC, 
but it also seems to exert a different, tumor suppressive role under different 
conditions. One should consider a role of TNC on epithelial regeneration, in 
particular the regeneration of acinar cells, as these cells differentiate to a ductal 
phenotype upon injury (Houbracken and others 2011). The molecular mechanisms 
underlying the effects of TNC on regeneration of acinar cells do not seem to be 
related to the Notch- or Wnt-pathways according to our expression data, but this 
aspect needs more detailed molecular investigation. Interestingly, the function of 
TNC seems to differ in already developed cancer.  
Paron and others could show that pancreatic cancer lines grown on a TNC substrate 
tend to proliferate and migrate more. This might play a role in the invasion and 
metastasis in patients (Paron and others 2011). PDAC was detected in only a 
subgroup of twelve months-old mice in this study. In this age group, 66.7 % of KC-
TNChet and 66.0 %KC-TNCko mice developed invasive, metastatic PDAC, 
meanwhile in the KC (TNC wt) group only 33.3 % mice had invasive, metastatic 
PDAC. Interestingly, in many cancer types as prostate and breast, TNC expression 
is linked with a poor prognosis (Emoto and others 2001, Ioachim and others 2002). 
In breast cancer, TNC seems to promote metastasis development (Oskarsson and 
others 2011). On the other hand, it was shown that in gliomas TNC has a role in 
tumor initiation, but not in tumor progression (Midwood and others 2011), which 
is more in line with the results of this study. In PDAC, no correlation between 
expression levels of TNC and prognosis could be found (Juuti and others 2004). 
Therefore, TNC might protect epithelia during stress but exert different functions 
once the tumor is evolved. Another explanation for these contradicting findings 
might be that the functions of TNC are not only context-dependent but also organ-
dependent. Finally, a down-regulation of TNC expression within advanced 
carcinomas may explain why TNC negative tumors have a worse prognosis in 
breast cancer and colorectal cancer (Chiquet-Ehrismann and others 2014).  
TNC might influence proliferation, even though there are contradictory findings 
(Midwood and Orend 2009). Therefore, when comparing the proliferation rates of 
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cells in ADM areas, PanIN and AFL between KC and KC-TNChet and KC-TNCko 
mice it could be shown that an absence or reduction of TNC protein does not only 
influence the architectural distortion but also enhances proliferation activity in areas 
of ADM. The fact that PanIN-1 lesions did not show any difference in proliferation 
compared to KC mice might be due to the small amount of cells that proliferate in 
PanIN-1 lesions (Aichler and others 2012). A possible way by which TNC could 
induce proliferation in epithelial cells is through its known function as an anti-
adhesive protein to promote wound healing in Kras challenged epithelial cells, 
herby exerting similar function as described in wound healing (Sible and others 
1995). Adhesion modulation is a key feature to influence cell proliferation, 
migration and differentiation.  More specifically, TNC is able to influence cell 
spreading and proliferation by interactions with fibronectin (Chiquet-Ehrismann 
and Tucker 2011). Moreover, large splice variants of TNC regulate the proliferation 
of for instance neural stem cells through the modulation of the expression level of 
epidermal growth factor (EGF) receptor (Brellier and Chiquet-Ehrismann 2012).  
TNC might influence apoptosis, even though the mechanisms are unclear 
(Midwood and Orend 2009). Further, apoptosis is an important feature in PDAC 
(Ruckert and others 2010). Therefore, the influence of absent TNC on apoptosis in 
early precursor lesions of PDAC was investigated. The small amount of apoptotic 
cells found here is in accordance with previously reported data in a mouse model 
of pancreatic β-cell carcinogenesis with a TNC ablation compared to the TNC wild-
type model. Interestingly, the TNC overexpressing model exhibited less apoptotic 
cells (Saupe and others 2013). This underlines the several and ambiguous functions 
of this protein and that a deregulated expression of TNC might influence tumor cell 
survival.  
As for apoptosis, no significant difference could be seen concerning the expression 
of p16, which is consistent with the complexity of mechanisms regulating the 
expression of this protein. All together these data show that the complex functions 
of TNC are still not completely understood and future work is needed to highlight 
the several function of this highly preserved protein (Chiquet-Ehrismann and others 
1986, Matei and others 2011). 
In TNC knockout mice, TNC is ablated in the complete organism and it is likely 
that other proteins are differentially regulated to compensate for the loss of TNC as 
for instance other members of the TN family (Chiquet-Ehrismann and Tucker 
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2011). An organ-specific ablation of TNC in the pancreas would give further 
insights in the role of TNC in pancreatic regeneration and, by crossing with PDAC-
mouse models, in pancreatic carcinogenesis. Furthermore, mouse models with a 
complete abrogation of the TN family or an overexpression of different splice 
variants of TNC could further help to clarify these points.  
3. The PDAC project as a practical application of the course 
After the successful completion of the web-based training course, students should 
have the basic knowledge to perform their own experiments with laboratory 
animals. To test this, this work serves as a test run for a student finishing the course 
and performing own mouse experiments afterwards. Together with the feedback 
collected from the students, this test system may serve as a quality control of the 
course. Several aspects learned during the preparation of the course could be used 
in the mouse experiments. For example, the C57BL6N background was chosen to 
generate the triple mutant animals, as this strains has no reported background 
lesions in the unchallenged pancreas and it is known for its secure expression of 
many mutations and exhibits a low spontaneous tumor incidence (Serpi and others 
2013). Furthermore, knowledge of necropsy and sampling techniques and of murine 
pancreatic histology was extremely useful for detection of early changes in 
pancreatic parenchyma. On the other side, the course was focused on basic aspects 
and detailed histopathological examination and immunohistochemical 
characterization of the specific model was achieved by working with the supervisor. 
Sundberg and others underscored that the training of a researcher investigating 
histopathological changes should be beyond the basics offered by this kind of 
courses and that it is very important to find a mentor (Sundberg and others 2012).  
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VI. SUMMARY 
Development of a training program for disease modeling and its practical 
application: morphological characterization of a genetically engineered mouse 
model for pancreatic cancer 
Animal models of human disease are increasingly used from basic science to 
preclinical drug development. This implicates a clear need for experts in 
histopathology of mouse models for human diseases and of specific programs to 
train these experts. The aim of this project was to develop an international, web-
based disease model training program for students with a higher university degree. 
Already existing national training programs from a consortium consisting of experts 
from Finland, Germany and Scotland were merged and included specialist in 
pedagogy, human and veterinary pathology, biochemistry and mouse models of 
human disease.  
The course comprised of a wide range of spontaneous background lesions in mouse 
strains (e.g. 129P2OlaHsd or C57BL6J), their gender and age differences, and 
physiological correlations. Similarities as well as differences with human pathology 
were highlighted. Moreover, the course included examples of basic lesions like cell 
adaptation, cell injury and cell death to the presentation of mouse models of human 
disease like the ductal adenocarcinoma of the pancreas (PDAC). By hosting a Pilot 
Course in spring 2013, the program was tested and feedback from student had been 
collected. Comparison of natural science students and medical students revealed a 
need for a tailored program depending on the basic education of the students. 
Based on this training program, a phenotyping of a mouse model of PDAC was 
performed using immunohistochemistry and morphometric analysis. This analysis 
was also used as a test run to evaluate the web-based training program. Tumor-
stroma interactions in PDAC, which is a very lethal disease, plays a key role and 
contributes to the highly aggressive nature of this cancer type. Tenascin-C (TNC), 
a protein of the extracellular matrix (EMC), is already overexpressed surrounding 
precursor lesions of PDAC. To investigate the impact of TNC on precursor lesions 
of PDAC and PDAC development in vivo, LSL-KRASG12D/+;Ptf1a+/Cre(ex1);TNC-
/- (KC-TNCko) and LSL-KRASG12D/+;Ptf1a+/Cre(ex1); TNC+/- (KC-TNChet) mice 
where compared to LSL-KRASG12D/+;Ptf1a+/Cre(ex1) (KC) mice at the age groups 1, 
2, 3 6, 9, 12 and 15 months. An earlier architectural distortion of pancreatic tissue 
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with fibrosis and inflammation was found in the KC-TNCko and KC-TNChet mice. 
To investigate the impact of TNC on precursor lesions, the focus of the investigation 
was set on young animals at the age of three months. The phenotype of precursor 
lesions and carcinomas were not influenced by the absence of TNC, but a higher 
frequency of PanIN lesions and carcinomas could be observed in KC-TNCko and 
KC-TNChet mice. Moreover, proliferation was elevated in KC-TNChet and KC-
TNCko animals in areas of acinar-ductal metaplasia; meanwhile no differences in 
apoptosis could be detected between the genotypes. These results implicate that of 
TNC might influence tumors cells only in later stages; meanwhile in early 
carcinogenesis it might be tempting to suspect an influence of TNC on epithelial 
regeneration.  
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VII. ZUSAMMENFASSUNG 
Entwicklung eines Trainingsprogrammes für Tiermodellpathologie und 
dessen praktische Anwendung: morphologische Charakterisierung eines 
genetisch veränderten Mausmodelles des Pankreaskarzinoms 
Da Tiermodelle zur Darstellung humaner Erkrankungen zunehmend sowohl in der 
Grundlagenforschung als auch in der präklinischen Medikamentenentwicklung 
verwendet werden, resultiert daraus ein klarer Bedarf an Experten, welche speziell 
ausgebildet sind, um pathophysiologische Veränderungen dieser Tiermodelle zu 
untersuchen. Ziel dieses Projekts war es, eine internationale, web-basierte 
Tiermodellplattform für das Pathologietraining für Studenten mit höherem 
Studienabschluss zu entwickeln. Hierzu wurden die nationalen und internationalen 
Trainingsprogramme der verschiedenen Teilnehmer des Konsortiums verbunden. 
Das Konsortium besteht aus Experten aus Finnland, Deutschland und Schottland 
mit Expertise in Pädagogik, humaner und Tierpathologie, Biochemie und 
Tiermodellen für humane Erkrankungen.  
Das Kursprogramm besteht zum einem aus einer großen Auswahl von spontanen 
Hintergrundläsionen, wie sie in bestimmten Mauslinien (z.B. 129P2OlaHsd oder 
C57BL6J) häufiger vorkommen, deren geschlechter- sowie altersbedingten 
Unterschiede, physiologische Zusammenhänge sowie Unterschiede zum Mensch. 
Zudem beinhaltet der Kurs Beispiele für grundlegende pathologische Läsionen wie 
Zellanpassungsreaktionen, Zellschäden und Zelltod. Des Weiteren erfolgt eine 
Präsentation von Mausmodellen und den zugehörigen humanen Erkrankungen wie 
dem duktalen Adenokarzinom des Pankreas (PDAC). Das Programm wurde durch 
einen im Frühjahr 2013 durchgeführten Pilot Course getestet, sowie der Feedback 
der Studenten gesammelt. Die Studenten äußerten sich sehr zufrieden über den Kurs 
sowie den Kursinhalt. Ein Vergleich von naturwissenschaftlichen und 
medizinischen Studenten ergab, dass das Programm auf die jeweilige 
Grundausbildung des Studenten zugeschnitten werden muss.  
Basierend auf diesem Kurs erfolgte eine tiefgehende immunhistochemische und 
morphometrische Phänotypisierung eines Mausmodells für das duktale 
Pankreaskarzinom. Diese Charakterisierung wurde zudem auch als ein Testlauf zur 
Kontrolle des web-basierten Trainingsprogrammes genützt. Im Pankreaskarzinom, 
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welches immer noch eine tödlich verlaufende Krankheit darstellt, spielen 
Interaktionen zwischen Tumorzellen und stromalen Zellen eine Schlüsselrolle und 
tragen somit zu der höchst aggressiven Natur dieses Tumors bei. Tenascin-C 
(TNC), ein Glykoprotein der extrazellulären Matrix, ist bereits im Stroma, welches 
Vorläuferläsionen das Pankreaskarzinoms umgibt, exprimiert.  
Um die Rolle von TNC auf die Vorläufer und die Entstehung des 
Pankreaskarzinoms in vivo zu untersuchen, wurden LSL-
KRASG12D/+;Ptf1a+/Cre(ex1);TNC-/- (KC-TNCko) und LSL-
KRASG12D/+;Ptf1a+/Cre(ex1);TNC+/- (KC-TNChet) Mäuse mit LSL-
KRASG12D/+;Ptf1a+/Cre(ex1) (KC) Mäusen in den Altersgruppen 1, 2, 3, 6, 9, 12 und 
15 Monaten verglichen.  
Hierbei konnte ein schnellerer Umbau des Pankreasgewebes mit Fibrose und 
Entzündung in den KC-TNCko und KC-TNChet Mäusen festgestellt werden. Um 
die Rolle von TNC auf die Vorläuferläsionen des Pankreaskarzinoms zu 
untersuchen, wurde der Fokus auf junge Tiere im Alter von drei Monaten gelegt. 
Der Phänotyp der Vorläuferläsionen und Karzinome wurde nicht durch die 
Abwesenheit von TNC beeinflusst, allerdings konnte eine erhöhte Anzahl von 
PanIN und Karzinomen in KC-TNCko und KC-TNChet Mäusen beobachtet werden. 
Zudem wurde eine erhöhte Proliferation in KC-TNCko und KC-TNChet Mäusen in 
Arealen mit azinär-duktaler Metaplasie gefunden, allerdings ergaben sich keine 
Unterschiede in der Anzahl der Apoptosen zwischen den verschiedenen Genotypen.  
Diese Ergebnisse implizieren, dass TNC die Tumorzellen erst in späteren Stadien 
beeinflusst, in der frühen Karzinogenese des Pankreaskarzinoms kann jedoch ein 
Einfluss von TNC auf die epitheliale Regeneration angenommen werden. 
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IX. ANNEX 
1. Web-based learning platform for comparative histology 
1.1. Material 
1.1.1. Laboratory equipment 
Unless indicated the companies or distributors were located in Germany. 
Product      Company 
 
1.1.2. Software 
Product      Company 
 
2. Example for phenotyping of a mouse strain: The TNC 
Axioskop 20 Carl Zeiss AG, Jena  
Aperio ScanScope CS  Aperio, Vista (USA) 
Iomega LDHD UP external storage Lenovo GmbH, Stuttgart 
Intenso 8GB USB stick Intenso GmbH, Vechta 
Adobe Acrobat 9 Pro  Adobe Systems GmbH, Munich 
Adobe® Connect™ Adobe Systems GmbH, Munich 
Adobe Photoshop Elements 5.0 Adobe Systems GmbH, Munich 
Aperio ImageScope Aperio, Vista (USA) 
Doodle Doodle AG, Zurich (CH) 
Moodle 2.5.1 eLeDia - E-Learning im Dialog GmbH, 
Berlin  
Skype 6.13 Microsoft, Redmond (USA) 
WebMicroscope University of Helsinki, Helsinki (FI) 
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model 
2.1. Material 
2.1.1. Reagents 
Product      Company 
3,3'-Diaminobenzidin  Medac GmbH, Wedel  
Acetic acid  Merck KGaA, Darmstadt  
Acid Fuchsin Sigma-Aldrich Chemie GmbH, Steinheim  
Agarose LE for gel electrophoresis Biozym Scientific GmbH, Hessisch 
Oldendorf  
Alcian Blue 8GX powder Sigma-Aldrich Chemie GmbH, Steinheim  
Alcin Blue 1 % MORPHISTO® Evolutionsforschung und 
Anwendung GmbH, Frankfurt am Main 
Antibody diluent Dako REALTM  Dako Deutschland GmbH, Hamburg  
Basic Fuchsin Sigma-Aldrich Chemie GmbH, Steinheim 
Bromophenol blue Sigma-Aldrich Chemie GmbH, Steinheim  
Chloroform  Merck KGaA , Darmstadt  
Citric acid Merck KGaA , Darmstadt  
Crocein scarlet-acid fuchsin MORPHISTO® Evolutionsforschung und 
Anwendung GmbH, Frankfurt am Main 
Dako Pen Dako Deutschland GmbH, Hamburg  
Dimethylsulfoxid  Sigma-Aldrich Chemie GmbH, Steinheim  
Discovery® MoMapTM Kit Roche Diagnostics, Mannheim,  
DNA-Loading dye 6X Thermo Fisher Scientific, Schwerte  
dNTP Set, 100 mM Solutions Life Technologies GmbH, Darmstadt  
Eosin Sigma-Aldrich Chemie GmbH, Steinheim  
Ethanol   Merck KGaA , Darmstadt  
Ethidium bromide Amresco, Solon (USA) 
Ferric chlorid  MORPHISTO® Evolutionsforschung und 
Anwendung GmbH, Frankfurt am Main 
Forene Isofluran Abbott GmbH & Co. KG, Wiesbaden  
Formalin Staub & Co. GmbH, Munich 
Generuler 100 bp DNA-Ladder ready to 
use  
Thermo Fisher Scientific, Schwerte  
Goat serum Abcam plc, Cambridge, (UK) 
Hemalm AppliChem GmbH, Darmstadt  
Hematoxylin Solution, Mayer’s Sigma-Aldrich Chemie GmbH, Steinheim  
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HistoMark Biotin-Streptavidin Peroxidase 
Kit 
KPL, Inc., Gaithersburg (USA) 
Hydrogen chloride neoLab, Heidelberg  
Hydrogen peroxide 30 %  Merck KGaA , Darmstadt  
Isoamyl alcohol Sigma-Aldrich Chemie GmbH, Steinheim  
Isopropanol   Merck KGaA , Darmstadt  
Light green SF yellowish Merck KGaA, Darmstadt  
Methanol  Merck KGaA , Darmstadt  
Nuclear fast red-aluminum sulfate solution 
0.1 %  
Merck KGaA , Darmstadt  
Orange G Sigma-Aldrich Chemie GmbH, Steinheim  
Peroxidase-labeled Streptavidin KPL, Inc., Gaithersburg (USA) 
Pertex mounting medium Medite GmbH, Burgdorf 
Phenol:Chloroform:Isoamyl alcohol 
25:24:1 
AppliChem GmbH, Darmstadt  
Phosphotungstic acid hydrate Sigma-Aldrich Chemie GmbH, Steinheim  
Picric acid Sigma-Aldrich Chemie GmbH, Steinheim 
Ponceau Xylidine   Sigma-Aldrich Chemie GmbH, Steinheim  
Potassium chloride Sigma-Aldrich Chemie GmbH, Steinheim  
Proteinase K Roche Diagnostics, Mannheim  
Rabbit Serum (10 %) KPL, Inc., Gaithersburg (USA) 
RNAlater® Life Technologies GmbH, Darmstadt  
Safron du Gatinais MORPHISTO® Evolutionsforschung und 
Anwendung GmbH, Frankfurt am Main 
Schiff’s reagent Sigma-Aldrich Chemie GmbH, Steinheim 
Sodium chloride Merck KGaA , Darmstadt  
Sodium dodecyl sulfate 20 % (w/v) 
solution  
AppliChem GmbH, Darmstadt  
Sodium periodate Sigma-Aldrich Chemie GmbH, Steinheim 
Taq DNA Polymerase BioTherm™ Ares Bioscience GmbH, Köln  
Trizma® base   Sigma-Aldrich Chemie GmbH, Steinheim  
Verhoeff stock solution A, B, C MORPHISTO® Evolutionsforschung und 
Anwendung GmbH, Frankfurt am Main 
Wash Buffer 10x Dako Deutschland GmbH, Hamburg 
Water, Aqua ad iniectabilia AlleMan Pharma GmbH, Rimbach  
Weigert's iron hematoxylin kit Merck KGaA , Darmstadt 
Xylene Merck KGaA , Darmstadt  
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2.1.2. Consumables 
Product      Company 
 
2.1.3. Laboratory equipment 
Product      Company 
Corning®DeckWorks® Pipette tips, 10 μl  Sigma-Aldrich Chemie GmbH, Steinheim  
Corning®DeckWorks® Pipette tips, 1000 
μl 
Sigma-Aldrich Chemie GmbH, Steinheim 
Corning®DeckWorks® Pipette tips, 20 μl  Sigma-Aldrich Chemie GmbH, Steinheim  
Corning®DeckWorks® Pipette tips, 200 
μl  
Sigma-Aldrich Chemie GmbH, Steinheim  
Coverslips  Carl Roth GmbH & Co.KG, Karlsruhe  
Cryotubes A. Hartenstein, Würzburg  
Dako Tube with cap Dako Deutschland GmbH, Hamburg 
Embedding cassettes A. Hartenstein, Würzburg  
Microscope Slides Gerhard Menzel GmbH, Braunschweig 
Injekt™ 2 mL LL Syringe B. Braun Melsungen AG, Melsungen 
Injekt™ 5 mL LL Syringe B. Braun Melsungen AG, Melsungen  
SuperFrost® Microscope Slides Gerhard Menzel GmbH, Braunschweig 
PCR tube strips 0.2 ml  Eppendorf AG, Hamburg  
PowerPac Basic Power Supply  Bio-Rad Laboratories GmbH, Munich  
Reaction tubes 1.5 ml  Eppendorf AG, Hamburg  
Reaction tubes 2 ml  Eppendorf AG, Hamburg  
Reaction tubes FalconTM Blue Max 15 ml BD Bioscience, Heidelberg 
Reaction tubes FalconTM Blue Max 50 ml BD Bioscience, Heidelberg 
Safe seal microtubes  Eppendorf AG, Hamburg  
Slide Storage Box A. Hartenstein, Würzburg  
Sterican® Hypodermic needle, 20G x 1 ½” B. Braun Melsungen AG, Melsungen 
Sterile Surgical Blade figure 26 C. Bruno Bayha GmbH, Tuttlingen 
Aperio ScanScope CS  Aperio, Vista (USA) 
Axioskop 20 Carl Zeiss AG, Jena  
Centrifuge 5415D  Eppendorf AG, Hamburg  
Centrifuge 5417R  Eppendorf AG, Hamburg  
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Dako Autostainer Universal Staining 
System 
Dako Deutschland GmbH, Hamburg  
Dissecting set type Ratisbon Medax-lithomed, Schweinfurt 
Eppendorf Mastercycler gradient  Eppendorf AG, Hamburg  
Eppendorf research pipettes  Eppendorf AG, Hamburg  
Gel documentation system Vilber Lourmat, Eberhardzell  
Glass coverslipper Promounter RCM2000 Medite GmbH , Burgdorf  
Heating block Thermomixer® comfort 1.5 
ml 
Eppendorf AG, Hamburg 
Heating block ThermoStat plus 1.5 ml  Eppendorf AG, Hamburg  
Heating oven type BE400 Memmert, Schwabach  
Heating plate HP 30 digital IKATHERM IKA®-Werke GmbH & CO. KG, Staufen  
Hotplate stirrer IKAMAG® RCT IKA® Werke GmbH und Co.KG, Staufen  
IKA® MS1 Minishaker  IKA® Werke GmbH und Co.KG, Staufen  
Ikamage® RCT magnetic stirrer  IKA® Werke GmbH und Co.KG, Staufen  
Incubator shaker Model G25  New Brunswick Sci., Edison (NJ, USA) 
Lab centrifuge 4K15  Sigma-Aldrich Chemie GmbH, Steinheim  
Laboratory balance BP 310 S  Sartorius AG, Göttingen  
Magnetic stir bars, various sizes NeoLab, Heidelberg 
Magnetic stirrer MR2000 Heidolph Instruments, Schwabach  
Microm HM 335 E Thermo Fisher Scientific, Schwerte  
Microtome blade Pfm medical AG, Köln  
Microwave Privileg 1034HGD  Otto, Hamburg  
Mitsubishi P95 printer  Mitsubishi Electric, Ratingen  
Nanodrop ND 2000c  Peqlab Biotechnology GmbH, Erlangen  
Paraffin Embedding System Medite TBS 
88 
Medite GmbH, Burgdorf 
pH-Meter (pH 211) HANNA Instruments GmbH, Kehl am 
Rhein  
Pressure cooker WMF, Geislingen/Steige  
Rocker table Rocky®   Fröbel Labortechnik, Lindau  
Scales Sartorius universal Sartorius AG, Göttingen  
Shandon Excelsior ES Thermo Fisher Scientific, Schwerte  
Spectrophotometer NanoDrop® ND-1000 Thermo Fisher Scientific, Schwerte  
Spectrophotometer UV/VIS Novaspec II
  
Pharmacia LKB, Uppsala (S) 
Stuart Scientific SD Rocking Platform STR  Keison products, Chelmsford (GB)  
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2.1.4. Buffer 
Citrate buffer for IHC 
Citric acid  10 mM 
pH 6 
 
Lysis buffer for DNA extraction  
TRIS-HCL, pH 8.0  50 mM 
NaCl    100 mM 
EDTA   100 mM 
SDS   1 % 
Proteinase K   0.5 mg/ml 
 
EDTA buffer for IHC 
EDTA   1 mM  
pH 8.0 
 
TBS 10X for IHC 
TRIS base   250 mM   
NaCl    1400 mM   
pH 7.5 
 
2.1.5. Software 
Product      Company 
Thermomixer compact  Eppendorf AG, Hamburg  
Tissue Cool Plate COP 20 Medite GmbH, Burgdorf 
Tissue Floatation Baths TFB 35 Medite GmbH, Burgdorf 
Vacuum Concentrator plus Eppendorf AG, Hamburg  
Vortexer MS1 Minishaker IKA®-Werke GmbH & CO. KG, Staufen 
Wide Mini Subset GT electrophoresis 
system  
Bio-Rad Laboratories GmbH , Munich  
Adobe Acrobat 9 Pro  Adobe Systems GmbH, Munich 
Adobe Photoshop Elements 5.0 Adobe Systems GmbH, Munich 
Aperio ImageScope Aperio, Vista (USA) 
Aperio SpectrumTM Plus Aperio, Vista (USA) 
Definiens Developer XD Definiens AG, Munich 
Definiens TissueStudio Definiens AG, Munich 
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Endnote X6 Endnote, Carlsbad (USA) 
IBM SPSS Statistics 21 IBM Deutschland GmbH, Ehningen 
Image J National Institutes of Health, Bethesda 
(USA) 
Microsoft Office 2010 Microsoft, Redmond (USA) 
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